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In the Rous sarcoma virus (RSV) Gag protein, the 25 amino acid 
residues of the p10 domain immediately upstream of the CA domain are 
essential for spherical immature particle formation. The significance of this 
finding was not known at the inception of this work. I performed a systematic 
mutagenesis on this region and found excellent correlation between the amino 
acid side chains required for in vitro assembly and those that participate in the 
p10-CA dimer interface in a previously described crystal structure. I then 
introduced exogenous cysteine residues that were predicted to form disulfide 
bonds across the dimer interface. Upon oxidation of immature particles a 
disulfide-linked Gag hexamer was formed, implying that p10 participates in 
and stabilizes the immature Gag hexamer. This is the first example of a critical 
interaction between two different Gag domains. Molecular modeling of the 
RSV immature hexamer performed by a collaborator, Paul Murray, indicates 
that the N-terminal domains of CA must expand relative to the modeled 
mature hexamer to accommodate the p10 contact. 
Replacement of the NC domain of HIV-1 Gag with an artificial 
dimerization domain has been shown to support assembly of virus-like 
particles in vitro and in cells. Similar systems for RSV Gag have yielded 
inconsistent results, suggesting that the requirements for RSV assembly may 
 
differ from those for HIV-1 assembly. I attempted to clarify these requirements 
in native avian cells and in vitro using chimeric Gag proteins in which NC was 
replaced by a leucine zipper domain or by an inducible dimerization domain 
based on the FK506-binding protein (FKBP). Budding of the Gag-leucine 
zipper fusion protein from avian cells was observed but was not entirely 
consistent, and similar fusion proteins failed to assemble in vitro. The Gag-
FKBP fusion proteins similarly failed to respond to the induction agent. I 
concluded that further characterization of Gag dimerization and of the 
sequence upstream of NC will be required before an assembly system based 
on artificial dimerization can be developed for RSV Gag. 
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CHAPTER ONE 
INTRODUCTION 
 
VIRUS STRUCTURE 
 
Basic properties of virus structure 
A virus particle, or virion, is a structure that assembles within an 
infected cell, exits, and then enters and infects a new cell. As such, the virus 
particle must meet two conditions. First, the virion must be able to withstand 
the extracellular environment for some period of time without loss of infectivity. 
Second, the virion must contain all of the components required for infectivity. 
These required components may include nucleic acid, protein, and lipid 
molecules. 
The fundamental component of all viruses is a nucleic acid genome that 
transmits the virus’s genetic information. The remaining components exist to 
protect and support the genome, to assist it to replicate itself, and to move it 
from cell to cell. The genome may consist of single- or double-stranded DNA 
or RNA, and single-stranded viral genomic RNA may be either positive- or 
negative-sense. As nucleases are ubiquitous in the cytoplasm and in the 
extracellular environment, the genome must be well protected within the virion 
in order to escape degradation. 
All virus particles also include viral proteins. Most of the proteins in a 
particle will be viral proteins, although many viruses package some host cell 
proteins as well. Some simple viruses, such as tobacco mosaic virus (TMV), 
have only a single type of viral protein present in virions, while the prototypical 
poxvirus vaccinia virus contains at least 63 viral proteins (132). Viral proteins 
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fall into two broad categories: structural and nonstructural proteins. Structural 
proteins are those that are necessary to form the virus particle, while 
nonstructural proteins, such as most viral enzymes, are not required to form 
the virus particle but are necessary for some other part of the viral life cycle. 
The division is not entirely simple, as many structural proteins have additional, 
non-structural functions. The structural proteins form a protective coat 
surrounding the non-structural proteins and the genome. 
Some viruses, known as enveloped viruses, also have an outer lipid 
envelope derived from the host cell membrane. Acquisition of this membrane 
is referred to as “budding.” The final envelope may be acquired at the plasma 
membrane or at internal cell membranes. The viral envelope typically contains 
viral and cellular membrane proteins. While host glycoproteins may be 
incorporated at random simply because they are present at budding sites, viral 
glycoproteins tend to be specifically incorporated into the envelope, and many 
viruses are actually unable to bud in the absence of their envelope proteins. In 
addition to protecting the contents, the envelope facilitates entry of the particle 
into an uninfected cell; it thus serves both structural and non-structural 
functions.  
 Virus structure is important at several stages of the viral life cycle. The 
structure ensures that all necessary components are incorporated into the 
assembling particle and maintains the stability of the virus particle, protecting 
the contents from environmental damage after release from the cell. Viral 
structure is also important after entry into a newly infected cell. In most cases, 
the particle must disassemble to release its functional components, a process 
known as uncoating. In more complex cases, such as in the rotavirus family, 
parts of the virus particle remain assembled and act as a factory for synthesis 
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of messenger RNA (70) or other viral molecules. In some cases, mutations 
that enhance virion stability can actually decrease infectivity, presumably by 
interfering with uncoating (40).The structure must balance these different 
functions in order to optimize infectivity. 
The presence of an envelope also influences virus structure. Since the 
envelope provides an additional layer of protection and containment, the 
protective function of the protein coat can be reduced. Non-enveloped viruses 
thus possess a dense and tightly packed protein coat called a capsid, made 
up of one or more layers of protein, to prevent degradation of the genome, 
while most enveloped viruses have a nucleocapsid within the envelope, with a 
relatively loosely packed protein coating the genome. Virus structure thus 
depends on the biological requirements of the particular virus. 
 
Virus structure and symmetry 
 The range of available virus structures is constrained by the inherent 
properties of the proteins that make up the viral coat. Most viral genomes 
encode only a few coat proteins, protein-protein interactions are very specific, 
and each protein molecule can make only a limited number of protein-protein 
contacts. One possible way to overcome these limitations is to arrange the 
coat protein subunits so that every subunit makes the same contacts with its 
immediate neighbors as every other subunit of the same type; in other words, 
to build a structure with extensive symmetry. Crick and Watson originally 
predicted in 1956 that viruses must have either helical or cubic (i.e. rotational) 
symmetry (27), and as virus structures were solved both forms of symmetry 
were observed.  
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In helical viruses, the molecules of a structural protein interact with the 
genome and each other to form a single helical structure, the length of which 
is determined by the length of the nucleic acid molecule enclosed (“open” 
structure). Helical symmetry is found in both non-enveloped viruses (mostly 
plant viruses, such as TMV, and bacteriophages) and enveloped viruses 
(including animal viruses, such as rhabdoviruses). 
 Cubic symmetry is more complex. Briefly, the requirement that each 
protein subunit be able to make identical contacts with its neighbors means 
that the virus must have axes of symmetry such that every subunit is 
indistinguishable from the others when rotated around those axes. 
Mathematically, only Platonic solids (regular convex polyhedra) can fulfill this 
requirement, and the five Platonic solids have only three patterns of symmetry 
among them. The three cubic symmetries available to viral coats are 
tetrahedral, cuboidal/octahedral, and dodecahedral/icosahedral. In practice, all 
regular virus structures solved to date have icosahedral symmetry. An 
icosahedron is a convex geometric solid with twenty faces (each an equilateral 
triangle), thirty edges, and twelve vertices. An icosahedral virus thus has six 
fivefold axes of symmetry (one through each pair of opposite vertices of the 
icosahedron), ten threefold axes of symmetry (one through the center of each 
pair of faces), and thirty twofold axes of symmetry (one bisecting each pair of 
edges). Since proteins are not symmetrical, each face of the icosahedron must 
consist of three protein subunits with symmetry about the threefold axis 
through the face. Therefore, in the simplest case, an icosahedral virus must 
consist of 60 (3 x 20) protein subunits (27). In such a virus, the subunits make 
pentameric interactions at each vertex, trimeric interactions at the center of 
each face, and dimeric interactions at each edge. Each subunit makes all 
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three interactions, and each interaction of a given type is identical for each 
subunit (Figure 1.1). 
 As there are limits to the size of viral structural proteins, a virus with a 
large amount of nucleic acid might require more than 60 such proteins to 
enclose the viral genome. In fact, while the smallest icosahedral viruses, such 
as parvoviruses, do contain the predicted 60 subunits, other icosahedral 
viruses are composed of many more. Placement of these extra subunits 
requires triangulation, or quasi-equivalence, in which some subunits will 
undergo subtle deformations in order to make inter-subunit contacts that are 
slightly different from those made by other subunits. Triangulation is modeled 
by asking how equilateral triangular “facets,” smaller than the faces of an 
icosahedron but each still consisting of three protein subunits, can be used to 
enclose a space while maintaining icosahedral symmetry. This is 
accomplished by building icosahedral fullerene structures, with subunit 
pentamers at each fivefold axis interspersed with hexamers between the 
vertices. Each subunit in a hexamer makes a six-fold interaction at the center 
rather than a fivefold interaction, meaning that the protein-protein contacts, 
while similar, cannot be identical; the three- and two-fold interactions are also 
very slightly different depending on whether the subunits involved are in 
pentamers or hexamers. These structures are categorized by the triangulation 
number T, where T represents the number of facets occupying each triangular 
face of the icosahedron. As each facet has three protein subunits, the total 
number of subunits per particle is 60T. Quasi-equivalence thus expands the 
range of sizes available to viruses without significantly increasing the required 
sizes of the viral proteins. 
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Figure 1.1: Icosahedral symmetry. A. T=1 virus with sixty protein 
subunits (orange commas). Symmetry axes are noted. B. T=3 virus with 
180 protein subunits. Pentamers are in orange, hexamers are in yellow 
and purple. Symmetry axes are noted. Figure take from reference (38). 
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 The sizes of icosahedral viruses are constrained by geometry. Only 
certain T numbers are compatible with icosahedral symmetry. The allowed 
numbers are those for which T=h2+hk+k2, where h and k are integers 
representing translations along the 0° and 60° axes of an equilateral triangular 
lattice (20). Icosahedral viruses employing classical quasi-equivalence may 
therefore have T numbers of the series 1, 3, 4, 7, 9…; T numbers up to 219 
(h=7, k=10) have been documented (131). The number of subunit pentamers 
is fixed at 12 (20), whereas the number of hexamers will increase with the T 
number; therefore, while a T=1 virus is composed only of pentamers, even a 
T=3 virus will have twice as many subunits in hexamers as in pentamers 
(Figure 1.1), while in large icosahedral viruses the pentamers will be vastly 
outnumbered. Therefore, large icosahedral capsids may be described as a 
lattice of hexamers with symmetrically placed pentamers. 
 
Exceptions to icosahedral symmetry 
While many virus structures conform to the rules above, viruses may 
also evade these principles in various ways by employing non-standard 
bonding. For example, the innermost protein shell of some reoviruses, while 
icosahedral, has a “disallowed” triangulation number of 2. This is 
accomplished by “geometrical quasi-equivalence,” in which the inner coat 
protein VP3 is able to make two somewhat different sets of contacts and thus 
occupy two different structural positions (48). Other viruses have “pseudo-
symmetry;” the classic example is the picornavirus family. Picornaviruses, 
such as poliovirus, contain 60 structural units, like a T=1 virus, but each unit is 
made up of four different proteins, three on the surface (VP1, VP2, VP3) and 
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one underneath (VP4). Because the three surface proteins, having different 
amino acid sequences, cannot make strictly quasi-equivalent bonds, and 
because of the hidden VP4 protein, picornaviruses are said to have pseudo-
T=3 symmetry (38). Certain bacteriophages, such as T4 phage, have 
elongated icosahedral heads with different T numbers for the end caps and 
the midpiece; for T4 phage, Tend=13 and Tmid=21 (39). Icosahedral symmetry 
or pseudo-symmetry is thus employed by a number of viruses that do not form 
strictly icosahedral capsids. 
Mathematically, a flat hexagonal lattice can be bent into a closed 
surface by the introduction of twelve pentameric “defects” at various positions 
without regard to icosahedral symmetry; therefore, by stretching the principle 
of quasi-equivalence, a virus could employ pentamers and hexamers of the 
same subunit protein(s) to form coats of various shapes (Figure 1.2) (47). It is 
thus possible for viruses to build many closed structures without strictly 
observing the principle of quasi-equivalence. 
 In addition to the variations on helical and icosahedral symmetry of viral 
coats, many viruses employ additional structural elements. The innermost coat 
of the bluetongue particle has been mentioned, but in addition to the T=2 shell 
of VP3, bluetongue cores have an outer layer of VP7 protein in a T=13 lattice, 
with a pentameric λ2 spike at each vertex (48). This core is further enclosed 
by an outer capsid layer consisting of three additional proteins (34). Enveloped 
viruses may, in addition to a protein-studded lipid envelope and a 
nucleocapsid, contain an intermediate matrix protein layer lining the inner 
surface of the envelope; influenza (orthomyxovirus) M1 protein is an example. 
The matrix protein may interact with the cytoplasmic tails of the membrane 
proteins, with the lipid bilayer itself, or with both (as does M1) (38). It is  
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Figure 1.2: Characteristic core shapes of three different retroviruses 
modeled as fullerene structures with a hexagonal lattice closed by 12 
pentagonal “defects.” The placement of the pentagons determines the 
core shape. Figure taken from reference (72). 
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 frequently responsible for the shape of the virus particle and may be sufficient 
to promote budding of virus-like particles of characteristic size and shape even 
in the absence of a nucleocapsid, as is the case for Ebola virus (55). These 
additional elements add further layers of complexity to virus structures. 
 
RETROVIRUSES 
 
Overview of retroviral biology 
 Retroviruses are a large and diverse family of animal viruses that cause 
significant disease in humans and in a number of domestic animal species. 
The best known retrovirus is Human Immunodeficiency Virus Type 1 (HIV-1), 
the causative agent of Acquired Immune Deficiency Syndrome (AIDS); as of 
2007, approximately 33 million people worldwide were thought to be infected, 
with 2.5 million new infections and 2.1 million AIDS-related deaths in the 
previous year (128). HIV-1, like most retroviral infections, is chronic and 
incurable, but the progression to AIDS and death can be quite slow; these 
properties have generated immense interest in the development of anti-
retroviral therapies, some of which have proven highly effective. However, the 
rapid development of drug resistance combined with the requirement for 
lifelong treatment requires continuous development of new and safer anti-viral 
drugs. Improved understanding of various aspects of retroviral biology will 
facilitate the development of improved therapies. 
 The hallmark of retroviral biology is reverse transcription, in which the 
virus violates the previously-held “central dogma of molecular biology” (26) by 
synthesizing DNA from an RNA template. This is accomplished by the viral 
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enzyme reverse transcriptase (RT), which makes a DNA copy of the +-sense 
single-stranded RNA genome during the early stages of infection. Reverse 
transcription is shared by the closely related spumaviruses, or foamy viruses 
(e.g. Human Foamy Virus), which contain a linear DNA genome generated by 
reverse transcription in the producing host cell, and by the more distantly 
related hepadnaviruses (e.g. Hepatitis B virus), whose gapped circular DNA 
genome is also made by reverse transcription (although the details of the RT 
mechanism are somewhat different) (8). Because RT lacks the 3’ exonuclease 
“proof-reading” domain found in most cellular DNA polymerases, it has a high 
error rate (approximately 1 x 10-4 per base pair) (119). This lack of fidelity has 
obvious drawbacks – each replication cycle produces many defective virions – 
but allows the virus to evolve rapidly to evade the host immune response and 
develop drug resistance. 
 The family Retroviridae is currently divided, based on evolutionary 
relationships, into seven genera: the alpharetroviruses (typified by Rous 
Sarcoma Virus, RSV), betaretroviruses (Mason-Pfizer Monkey Virus, MPMV), 
gammaretroviruses (Murine Leukemia Virus, MLV), deltaretroviruses (Human 
T-cell Leukemia Virus type 1, HTLV-1), epsilonretroviruses (Walleye Dermal 
Sarcoma Virus, WDSV), lentiviruses (HIV-1), and spumaviruses (Human 
Foamy Virus, HFV). The spumaviruses are most distantly related to the others 
and are classified as a separate subfamily, the spumaretroviridae, while the 
other six genera make up the subfamily orthoretroviridae (37). 
 All retroviruses share three genes: gag, pol, and env. The gag gene 
encodes the major structural protein Gag (group-specific antigen), the pol 
gene encodes the viral enzymes RT and integrase (IN), and the env gene 
encodes the viral glycoprotein Env. Either gag or pol also encodes the viral 
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protease PR. The gag and pol gene products are typically translated from the 
same open reading frame of a full-length unspliced viral RNA, such that both 
Gag and Gag-Pol are produced by either a frameshift (e.g. RSV) or a read-
through (e.g. MLV) mechanism. Both Gag and Gag-Pol are polyproteins that 
are cleaved post-translationally by the viral protease PR. Env is translated 
from a separate spliced mRNA. The “simple” retroviruses have only these 
three genes, while the “complex” retroviruses have additional “accessory” 
genes that are beyond the scope of this introduction (Figure 1.3). The 
betaretroviruses, deltaretroviruses, epsilonretroviruses, lentiviruses, and 
spumaviruses have complex genomes, while the alpharetroviruses and 
gammaretroviruses have simple genomes. The lentiviruses are further 
distinguished by their ability to infect non-dividing cells (which does not wholly 
depend on the accessory gene products (12)), whereas most of the other 
orthoretroviridae infect only dividing cells. Lentiviruses also tend to cause 
immunodeficiency disease, while the other orthoretroviruses cause mostly 
neoplastic disease. 
 
The retroviral life cycle 
 The retroviral life cycle is divided into two stages, early and late (Figure 
1.4). The early stage includes those steps which lead to infection of a host cell. 
It begins when the incoming virus particle binds to one or more cellular 
receptors via the Env protein, which then undergoes a conformational change 
to initiate fusion of the viral envelope with the host cell membrane. Fusion may 
occur at the plasma membrane (e.g. HIV-1) or following receptor-mediated 
endocytosis and endosomal acidification (e.g. RSV (89)). The viral core is 
released into the cytoplasm, where reverse transcription takes place. The core  
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Figure 1.3: Comparison of simple (ALV aka RSV) and complex (HTLV) 
retroviral genomes, Vertical spacing represents different open reading 
frames, horizontal gaps represent open reading frames accessed by 
alternative splicing. Figure taken from reference (121). 
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Figure 1.4: Schematic representation of retroviral life cycle showing early 
and late events of replication. Figure adapted from reference (121). 
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then “uncoats” to release the “pre-integration complex” (PIC), which consists 
of the viral DNA, integrase, and other viral and cellular components. The PIC 
enters the nucleus by active importation (lentiviruses) or during mitosis (simple 
retroviruses). There, the viral DNA is integrated into the host’s chromosomal 
DNA. Integration marks the end of the early stage of replication, and cells that 
contain integrated viral genomes are regarded as infected. 
The late stages of retroviral replication are those which produce the 
virus particle. First, the viral DNA is transcribed by cellular RNA polymerase II, 
producing both full-length (Gag and Gag-Pol) and spliced (Env and accessory 
proteins) mRNAs. These mRNAs are exported from the nucleus (full-length 
mRNAs depend on either special cis-acting sequences or accessory gene 
products for export) and translated by either free (full-length) or membrane-
bound (Env) ribosomes to yield viral proteins. The Gag protein recognizes and 
binds the full-length viral RNA via a secondary structure-rich 5’ “packaging 
signal” known as Ψ (psi). The full-length viral RNA serves as both mRNA for 
Gag and Gag-Pol and as genomic RNA, although it is not clear whether the 
same molecules are both translated and packaged. The Gag-RNA complex is 
transported to the plasma membrane by an unknown mechanism. At the 
membrane Gag assembles into virus particles and also interacts with 
components of the cellular ESCRT (Endosomal Sorting Complex Required for 
Transport) complex (125). In uninfected cells, the ESCRT complex is involved 
in the budding of vesicles into late endosomes (multi-vesicular bodies) and in 
cytokinesis (86), processes topologically similar to viral budding from the 
plasma membrane. Retroviral Gag proteins contain “late domains,” generally 
tetrapeptide motifs, which interact with various ESCRT proteins and recruit 
them to sites of viral budding; in the absence of viral late domains or of 
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ESCRT components, budding virus particles display a “late domain 
phenotype” in which the particle remains tethered to the cell surface by a 
membrane stalk (Figure 1.5).  
During budding the Env protein is incorporated into the viral envelope. 
While envelope protein incorporation can be passive (as when pseudotyping 
retroviral particles with the VSV-G protein), there is evidence that retroviral 
budding sites actively recruit Env in a somewhat virus species-specific 
manner; for example, HIV-1 budding sites recruit both HIV-1 Env and VSV-G 
proteins, but not RSV Env protein (Marc Johnson, personal communication). 
HIV-1 may exploit the cellular protein TIP47 in order to recruit HIV-1 Env (75). 
During or shortly after release, the viral protease is activated and cleaves Gag 
and Pol polyproteins into their constituent domains. Cleavage by PR results in 
morphological changes to the particle termed maturation; blocking PR 
cleavage produces non-infectious “immature” particles. Maturation is the final 
step of the late stage of retroviral replication. 
 
The retroviral Gag protein 
 The structural protein Gag is both necessary and sufficient for retroviral 
assembly, meaning that the Gag protein alone, when expressed in cells, will 
assemble and bud to produce virus-like particles. Such particles lack the viral 
genome, enzymes, and envelope protein and are thus completely non-
infectious, but they resemble authentic immature particles in shape, size, 
appearance by transmission electron microscopy (TEM), and radial density 
profile (41). (In the case of RSV, which has PR as part of Gag instead of Gag-
Pol, the virus-like particles undergo maturation as well.) Therefore, in  
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Figure 1.5: Budding particle displaying “late domain phenotype,” in which 
the particle appears to be fully assembled but remains tethered to the cell 
surface by a membrane stalk. Figure take from reference (116). 
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discussions of retroviral structure and assembly, the Gag protein is frequently 
considered alone. 
Gag is a polyprotein that is cleaved by the viral protease PR during or 
shortly after virus budding and release. All retroviruses have three PR 
cleavage domains in common: the protein-lipid interaction domain MA, the 
protein-protein interaction domain CA, and the protein-nucleic acid domain 
NC. The remaining cleavage products vary among retroviral families. High-
resolution structures have been obtained for each of the major cleavage 
products, although not for the entire protein. While there is little sequence 
identity among retroviral Gag proteins, the secondary and tertiary structures of 
the major cleavage domains are remarkably similar, allowing comparisons 
between different retroviruses. Based on these domain structures, Gag is a 
predominantly helical protein, with no significant amount of β-sheet structure. 
There is some evidence for intramolecular inter-domain interactions in the 
soluble state (29), but as the significance of these interactions is not yet clear 
it remains profitable to consider the cleavage products as independent protein 
domains. 
 The MA domain is primarily responsible for interacting with cellular 
lipids. The retroviral MA domains studied to date have an N-terminal helical 
“membrane binding domain” (MBD) and a C-terminal extension which is 
frequently dispensable for assembly and budding (90, 135), and for replication 
in RSV (92), but not for early steps of replication in HIV-1 (135). In HIV-1, the 
C-terminus appears to be important for Env incorporation (136), although the 
site of interaction between MA and TIP47 is in the MBD (75). The MBD, or “M 
domain” (95), consists of four helices and a short mixed β-sheet packed into a 
globular domain. A fifth helix connecting to the C-terminus projects away from 
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the globular domain, and the C-terminus itself is unstructured. The MA-lipid 
interaction is predominantly electrostatic, with a basic patch on the MBD 
interacting with negatively charged phospholipids. In addition, the MA proteins 
of most retroviruses are myristylated at the N-terminus, although those of RSV 
and equine infectious anemia virus (EIAV) are not. While the fatty acid 
modification contributes to membrane affinity, the electrostatic interaction 
predominates (28). In solution structures, unmyristylated HIV-1 MA proteins 
are monomeric, while in crystal structures the unmyristylated protein is 
trimeric; the myristylated protein exists in both states in solution, with the 
myristate sequestered in the monomer form and exposed in the trimer (117). 
This “myristyl switch” is thought to couple membrane binding to assembly, 
although it is not clear that MA forms trimers in either the immature or the 
mature virus particle. HIV-1 and EIAV MA proteins also contain a 
phosphatidylinositol-4,5-bisphosphate (PI4,5P2) binding pocket that is thought 
to target assembly to the plasma membrane, and PI4,5P2 binding may also 
activate the myristyl switch (21, 103). 
 The CA domain is the major protein-protein interaction domain of Gag. 
The CA domain of Gag drives both mature and immature assembly. This is 
obvious in the case of mature assembly, in which the outer shell of the core 
consists of CA alone. For immature assembly, the CA domain of chimeric Gag 
molecules is what determines Gag-Gag interactions. Chimeric Gag can co-
assemble with and complement other Gag molecules with homologous CA 
domains, but not those with non-homologous CA domains (2, 71). The CA 
domain also determines the size and core morphology of immature virus-like 
particles (2).  
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 The CA protein consists of independently folded N- and C-terminal 
domains (NTD and CTD) connected by a short flexible linker (19, 62) (Figure 
1.6). The N-terminal domain consists of a short N-terminal β-hairpin and seven 
α-helices. The β-hairpin is stabilized by a salt bridge between the amino 
terminus of the conserved initial proline residue of CA and the side chain of a 
conserved aspartate in helix 3. Therefore, the β-hairpin forms only after PR 
cleavage (which liberates the amino terminus of proline 1) and does not exist 
in the Gag precursor protein.  
 Several studies have addressed the NTD structure prior to PR 
cleavage. An NMR structure has been obtained for an HIV-1 Gag fragment 
containing MA and the N-terminal domain of CA (118). The β-hairpin region of 
the NTD (Figure 1.6, arrows) is unfolded, as predicted when the N-terminus of 
proline 1 is not free to form the anchoring salt bridge. This unfolding produces 
an approximately 2 Å shift of helix 6 and the helix 4-5 loop, but the remainder 
of the NTD structure is similar to that obtained for the mature NTD. A solution 
structure was recently obtained for a similarly “immature” MLV construct 
containing the NTD of CA and the upstream domain p12 (67). Like the HIV-1 
structure, the NTD portion of the protein resembles the structure of the mature 
NTD with the β-hairpin unfolded. The upstream p12 domain is unstructured, 
highly mobile, and does not interact with the NTD. This is in striking contrast to 
a structure of the RSV NTD with an N-terminal 25 amino acid extension into 
the upstream p10 domain. The RSV extended NTD crystallized as a dimer 
with an extensive intermolecular p10-CA interface (91) (Figure 1.7). The 
significance of this dimer was not certain prior to the work described in this 
thesis, but it seemed unlikely that the RSV extended NTD dimer could be 
representative of the state of the NTD in immature virus particles. Thus, while  
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RSV CA RSV HIV
NTD
CTD
Figure 1.6: Left: Structure of full-length RSV CA protein. Right: 
Comparison of NTD and CTD from RSV and HIV. Note similarities of 
tertiary structure despite lack of sequence homology. Red arrows indicate 
N-terminal β-hairpins. Figure adapted from reference (64). 
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Figure 1.7: RSV extended NTD structure (91). NTD residues are in blue 
and p10 residues in yellow. Note the lack of β-hairpin and the large p10-CA 
interface. 
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it is certain that the conserved β-hairpin is found only in the post-cleavage 
form of the NTD, the significance of hairpin formation is not clear. 
 In contrast to the situation for the NTD in the context of Gag, the 
structure of the mature NTD in the context of the mature virus particle has 
recently been established. The NTD of murine leukemia virus (MLV) has been  
crystallized as a hexamer that is believed to represent its state in the mature 
core (87, 88). The hexamer is formed by interactions among the first three 
helices of each subunit, as previously predicted by mutagenesis of the HIV-1 
NTD (124). Interactions among the β-hairpins may contribute to the hexamer 
interface. The packing of the hexamers within the crystal may also be relevant 
to assembly (87) (S.P. Goff, personal communication), although this remains 
in dispute. Both the structure and the role of the NTD in mature particles are 
thus well characterized. 
 The C-terminal domain of CA consists of four helices. The CTDs of 
HIV-1 and EIAV, but not that of HTLV-1, crystallize as dimers mediated by 
hydrophobic interactions between side chains on helix 2. The RSV CA CTD 
has been crystallized as a monomer (64) and as a dimer (Richard Kingston, 
personal communication). HIV-1 CA is also dimeric in solution (42) due to the 
CTD-CTD interaction, although EIAV CA is monomeric in solution (7) and 
dimerizes only in the crystal structure. Most retroviral CA proteins (although 
not that of RSV) have a pair of cysteine residues in helices 3 and 4 of the CTD 
that form an intramolecular disulfide bond in the HIV-1 and EIAV crystal 
structures. The disulfide bond is not present in freshly prepared HIV-1 particles 
(81), in the monomeric soluble EIAV CA (7), in the solution structure of HTLV-
1 CA (62), or in the recently obtained NMR structure of a monomeric mutant of 
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the HIV-1 CTD (129). The correlation between disulfide formation and 
dimerization is intriguing, but its significance remains debatable.  
 The CTD also contains the major homology region (MHR), a 20 amino 
acid sequence with unusually strong sequence identity among the retroviruses 
(and, to a lesser extent, in some retrotransposons (24, 93, 100) and in the 
distantly related hepadnaviruses (141)). The MHR occupies the N-terminal 
loop and part of the first helix of the CTD. Mutation of the MHR can be rescued 
by second-site mutations in both the NTD and CTD (98), suggesting a 
complex role for the MHR in assembly and infectivity. Recently, a mammalian 
SCAN domain structure was found to have significant structural homology to 
the retroviral CTD (53). The SCAN dimer appears to be a “domain-swapped” 
analog of the CTD, in which helix 1 is “exchanged” between the subunits and 
makes dimer contacts very similar to the intramolecular contacts in the 
monomer. The HIV-1 CTD can be manipulated by deletion of an amino acid in 
the CTD helix 1-2 loop to crystallize as a similar domain-swapped dimer (54), 
and MHR residues are involved in the interface. While the significance of this 
finding is not clear, it is an intriguing model as it assigns an assembly function 
to the MHR. 
 The NC domain of Gag is relatively short and unstructured. The domain 
has a strong net positive charge, and the NC-RNA interaction, like that 
between MA and membrane phospholipids, is thought to be largely 
electrostatic. NC domains of all but the spumaviruses also contain one or two 
zinc finger structures (sometimes called “zinc knuckles” due to their length, 
which is short compared to canonical zinc finger domains), consisting of a 
CCHC motif coordinating a zinc (II) ion. The zinc fingers are required for 
specific packaging of viral RNA during assembly (122) and also for proper 
 24
reverse transcription and integration in the early stages of the retroviral life 
cycle . The remainder of the NC protein is unstructured in its unbound state; 
additional folding is apparently induced by binding to RNA. NMR structures of 
psi sequences bound to NC show the zinc fingers interacting with various RNA 
secondary structural elements (6, 30, 138). NC has occasionally been called 
dispensable for budding (94), although most investigators find that it is 
required for particle production (108, 109, 126), most likely because NC-RNA 
binding initiates Gag assembly. Recent studies of the RSV Gag protein 
suggest that the first four amino acids of RSV NC are part of a structural 
element that also includes the SP linker domain that joins the CA and NC 
domains and the C-terminal tail of CA (60). Therefore, NC may have as many 
as three separate functions in retroviral particle production. 
 
Special aspects of RSV Gag 
 As this laboratory uses RSV as a model to study retroviral assembly, 
some special consideration of the RSV Gag protein is warranted. In addition to 
the three primary domains (MA, CA, and NC), RSV contains four additional PR 
cleavage domains: p2 and p10 between MA and CA, SP between CA and NC, 
and PR itself C-terminal to NC (Figure 1.8). The p2 domain has no known 
structural significance but contains the primary RSV late domain, the Nedd4 
ubiquitin ligase-binding motif PPPY (63). The p10 domain has at least two 
functional elements. The N-terminal half of p10 contains the secondary late 
domain, the Alix-binding motif LYPSL (Kari Dilley, personal communication). 
The last 25 amino acids of p10 are required for correct RSV particle 
morphology (56, 58) and are those included in the extended NTD structure 
previously described; these 25 residues are the focus of Chapter Three of this  
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Figure 1.8: The RSV Gag protein. Vertical lines represent PR cleavage 
sites. Note that the 22 amino acid p2 and the 12 amino acid SP domains 
undergo an additional internal cleavage. 
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thesis. The SP domain has not been well characterized, but it too appears to 
be required for spherical particle morphology: interruption of a putative 
structural element consisting of the unstructured C-terminal tail of CA, SP, and 
the N-terminal four amino acids of NC has been shown to produce cylindrical 
particles when expressed in cells (60). Finally, for RSV, the PR coding 
sequence is before the Gag-Pol frameshift, so PR is part of Gag rather than of 
Gag-Pol. This means that an RSV particle contains many more molecules of 
PR than most retroviral particles, but this has no known significance for the 
function of Gag itself. 
 
Retroviral particle structure 
 The structural biology of retroviruses is complicated by the fact that 
retroviral particles exist in two forms: mature and immature (Figure 1.9). 
Maturation is a consequence of cleavage by the viral protease PR, which 
separates the domains of Gag during or shortly after viral budding. The mature 
particle is the infectious form, and immature particles are rarely observed 
under natural conditions, although they may be produced by disrupting the 
activity of the retroviral PR protein by mutation or drug treatment. Little is 
known about the timing of PR activation or maturation. The infrequent 
observation of immature particles suggests that maturation must occur almost 
simultaneously with budding. However, the tethered particles characteristic of 
the “late domain phenotype” appear to be immature even when an active 
protease is present, suggesting that maturation cannot occur until budding is 
complete. This delay suggests that the immature particle, while not infectious, 
is a necessary intermediate worthy of study. 
 27
  
E. 
Figure 1.9: Morphological maturation of retroviral particles. Immature form 
is on the left, mature form is on the right. A. MLV, B. MPMV, C. HTLV-1, 
D. HIV. EM images taken from reference (116). E. HIV maturation 
cartoon. Immature particle is on the left, mature particle is on the right. 
Red dots represent MA, double black dots represent CA, green dots 
represent NC. Diagram taken from reference (10). 
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 Morphological maturation is dramatic at the level of electron 
microscopy. Viewed by thin-section transmission electron microscopy (TEM), 
the mature particle has a central, electron-dense core, which consists of a 
shell of CA protein enclosing the dimeric RNA genome and associated NC 
protein. Env protein spikes are clearly visible projecting from the outer surface 
of the envelope, and the MA protein coats the inner surface of the lipid 
envelope. The arrangement of the MA molecules remains to be elucidated; 
while the isolated protein forms trimers in crystal structures and hexamers in a 
2D lattice (5), no evidence yet exists for an organized MA lattice in retroviral 
particles (11). The CA shell has been studied extensively and is thought to be 
based on a “fullerene” model in which a hexameric lattice is closed by twelve 
pentameric defects (47) (Figure 1.2). Numerous reconstructions of two-
dimensional crystals and cylindrical CA assemblies suggest that the NTD of 
CA forms hexamers that are linked together by CTD dimers (46, 47, 72, 80) 
(Figure 1.10). The hexameric crystal structure of the NTD of MLV CA (88) 
supports the reconstructions and is believed to represent the mature NTD 
hexamer. The CTD dimer in 2-D reconstructions of HIV-1 CA lattices does not 
appear to be a perfect match for either the canonical “face-to-face” dimer or 
the domain-swapped crystallographic dimer, although it is closest to the former 
(44). The structure of the shell’s contents – the RNA, and the NC, RT, and IN 
proteins – remains largely unexplored. 
 In contrast to mature particles, immature particles examined by thin-
section TEM have an electron lucent center and an electron-dense ring 
underlying the lipid envelope. The identity of the dense ring is not clear; it may 
represent either the closely packed CA domains of Gag or the associated NC 
domains and RNA. The Gag molecules are thought to be arrayed radially, with  
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Figure 1.10: A. HIV CA reconstruction representative of mature particle. 
NTD hexamer is in green with interface depicted by red dots. CTD dimers 
are in blue with interface depicted by yellow dots. Figure taken from 
reference (44). B. Immature HIV particle cryotomography with Gag 
modeled in. NTD hexamers are blue, CTD dimers are yellow, downstream 
“pillar” structures are magenta. C. Comparison of immature and mature 
lattice arrangements. Color scheme as in B. Panels B and C taken from 
reference (130). 
 
 30
the MA domain contacting the lipid envelope and the NC domain interacting 
with the viral RNA toward the center of the particle. Radial density profiles of 
immature particles obtained by cryo-electron microscopy support this 
hypothesis, showing concentric layers of density interpreted as MA, the N- and 
C-terminal domains of CA, and NC (10, 41, 50, 133). The MA domain layer of 
the immature particle, as examined by cryo-electron microscopy diffraction 
(10) and single-particle cryotomography (130), does not display a regular 
protein lattice. The CA layer is superficially similar to that of the mature 
particle, with NTD hexamers linked by CTD dimers (130) (Figure 1.10). There 
are, however, significant differences. The immature core contains more 
molecules of Gag than the mature CA shell does of CA. The exact numbers 
remain controversial, but the difference may be as much as two-fold for HIV-1 
(10, 11). The lattice spacing (the distance between the centers of the 
hexamers) of the immature CA is correspondingly smaller, 8 nm for immature 
particles vs. 9 nm for HIV-1 mature particles (10, 11, 47, 72, 130). These 
differences have two implications. First, since the lattice spacing is different, 
the CA-CA contacts made by Gag are somewhat different than those made by 
mature CA. Second, since the number of molecules is different, the immature 
lattice must at least partially disassemble before the mature lattice forms. 
 Single-particle cryotomography revealed three surprising features of the 
immature HIV-1 particle (130). First, the Gag lattice appears to be incomplete, 
with substantial areas containing no organized Gag at all; this property may 
account for the diverging estimates of the number of Gag molecules in the 
core, as some methods have assumed a complete lattice. Second, the NTD 
hexamers were larger than expected. Since the immature lattice spacing is 
smaller than that of the mature lattice, the increased hexamer diameter means 
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that the immature hexamers must be much more tightly packed than the 
mature hexamers, presumably due to differences in the CTD-CTD 
interactions. The hexamers themselves were also surprising: rather than 
resembling solid disks, as in the hexameric MLV NTD crystal structure, they 
appeared as rings with large central cavities (Figure 1.10). No direct NTD-
NTD interactions were observed within the hexamers, although the resolution 
of this technique is not sufficient to say that none exist. Third, the “spacer” 
region between CA and NC formed prominent pillar-like structures which lay 
below the central cavities of the NTD hexamers. As the spacer region of HIV-1 
Gag has been reported to form a long α-helix under some conditions(83), it 
has been suggested that the pillar formations are six-helix bundles, although 
the resolution was not sufficient to establish this definitively. Whatever their 
structure, these pillars effectively tether the C-terminal domains of Gag below 
the NTD hexamers and may thus be responsible for the tight packing of the 
immature lattice. These three features have also been observed for RSV 
particles (John Briggs, personal communication) and may thus reflect general 
principles of retroviral immature structure. 
 The mechanism by which PR cleavage leads to morphological 
maturation is still unclear, although improvements in the understanding of the 
structures of immature and mature particles are beginning to elucidate this 
process. For example, cleavage between CA and the downstream spacer 
domain, which separates the CTD from the putative six-helix bundles, 
presumably allows a rearrangement of the CTD dimers relative to the NTD 
hexamers. At the N-terminal end of CA, the formation of the β-hairpin after PR 
cleavage is likely to play a role in maturation. The β-hairpin appears to be 
critical for mature core assembly. It forms a large part of the NTD-NTD 
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interface in the MLV hexamer (88), and the salt bridge is required for correct 
mature morphology for both HIV-1 (123) and Mason-Pfizer Monkey Virus 
(MPMV) (120) although apparently not for HTLV-1 (9). There is thus a putative 
candidate at each end of the CA protein for the switch to mature morphology. 
 For RSV, there is a more explicit link between maturation and PR 
cleavage at the N-terminus of CA: a sequence upstream of CA is required for 
immature morphology. Removal of the last 25 amino acids of the p10 domain 
of Gag results in the formation of cylindrical particles believed to represent 
mature cores (18) (as purified HIV-1 CA also assembles into tubes in vitro (36, 
45)). Therefore, the upstream sequence, which would be removed by PR 
cleavage during the normal life cycle, is directly responsible for the change in 
morphology. A structure obtained for an RSV NTD extended N-terminally to 
include the C-terminal 25 amino acids of p10 showed an antiparallel dimer 
with an extensive p10-CA interface (91) (Figure 1.7). As will be shown in this 
thesis, this structure is in fact relevant to immature assembly. 
 
RETROVIRAL ASSEMBLY 
 
Assembly in cells 
 The process by which retroviral particles assemble in cells is poorly 
understood. Two general assembly pathways have been described. Most 
retroviruses appear to assemble in association with the cellular membranes 
from which they bud. The exact location of assembly and budding is 
somewhat controversial, particularly for HIV-1 in monocyte-derived cells (99, 
127), but in general most retroviruses are thought to assemble at and bud 
from the plasma membrane in most cell types. In the alternate pathway, 
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formerly known as type-B or type-D assembly, immature particles assemble in 
the cytoplasm near the microtubule organizing center (MTOC) and are 
subsequently transported to the plasma membrane for budding. This pathway 
is used by the betaretrovirus and spumavirus families. Pericentriolar assembly 
is dictated by a “cytoplasmic retention targeting signal” (CTRS) located within 
the Gag protein (22, 134). For MPMV, mutation of the CTRS redirects 
assembly to the plasma membrane (114), while for primate foamy virus 
mutation of the CTRS abolishes assembly (35). Re-targeting Gag to the 
plasma membrane can even rescue assembly-defective MPMV (107). 
Therefore, assembly at the plasma membrane appears to be the “default” 
retroviral assembly pathway. 
 To date, most work on the retroviral assembly process (as opposed to 
specific requirements for assembly and/or budding) has focused on 
identification of assembly intermediates. Under some circumstances, 
assembly within cells tolerates the replacement of the NC domain of Gag with 
a coiled-coil dimerization domain such as the leucine zipper domain from 
CREB or GCN4, suggesting that Gag dimerization is sufficient to initiate 
assembly (1, 56, 137). The particles produced do not package viral RNA (137) 
and may contain no RNA at all (Alan Rein, personal communication). HIV-1 
Gag-containing complexes of discrete sizes have been identified by 
sedimentation analysis, suggesting an ordered assembly pathway in which the 
size of the Gag complex increases in a stepwise fashion (32). This process 
appears to involve the cellular ATP- and RNA-binding protein ABCE1 (33), 
which interacts with Gag via basic residues in the NC domain (73). This 
interaction is independent of RNase treatment, although an RNA-mediated 
interaction is difficult to exclude completely. ABCE1 is recruited to HIV-1 
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budding sites but appears to dissociate from Gag prior to budding, although 
budding rate is decreased and the ABCE1-Gag association is prolonged in 
cells in which HIV-1 PR is not expressed (33). Despite this information, the 
role of ABCE1 in HIV-1 assembly is not yet clear.  
Large RSV Gag-containing complexes have also been isolated by 
sedimentation (69).These complexes may correspond to large cytoplasmic 
aggregates of Gag-GFP observed in the same study, which were thought to 
contain cellular proteins as well as Gag. The exact sizes and nature of these 
cellular Gag complexes remain poorly understood. 
 Cell-based assembly assays are less than ideal for the study of 
retroviral assembly. While host cell factors required for assembly are best 
identified and studied in cells, the cell is a complex environment in which any 
change may affect many apparently independent processes. When studying 
viral assembly, the number of these potentially confounding processes – 
transcription, translation, nuclear transit (in some cases), membrane-binding, 
trafficking, and budding – can be prohibitive. More controlled systems are thus 
desirable in order to isolate and study retroviral assembly. 
 
In Vitro assembly systems 
 
Cell-free systems 
 Two cell-free expression systems have been used extensively for the 
study of retroviral assembly. The first is an MPMV system based on rabbit 
reticulocyte extracts. MPMV is a betaretrovirus, so as described above normal 
cellular MPMV assembly takes place at a cytoplasmic site near the MTOC 
rather than at the plasma membrane; the cytoplasmic virus-like particles are 
 35
then trafficked to the plasma membrane following assembly. The cell-free 
MPMV assembly system requires the addition of in vitro transcribed MPMV 
mRNA to the extract. The mRNA is translated by ribosomes in the extract, 
producing, by frameshifting, two products: Gag and Gag-Pro. (Full-length 
MPMV RNA can undergo two possible frameshifts to produce Gag, Gag-Pro, 
and Gag-Pro-Pol, but mRNA capable of expressing the full-length Gag-Pro-Pol 
protein could not be transcribed in vitro.) These two proteins assemble into 
virus-like particles whose density and TEM morphology are comparable to 
immature MPMV cores. While Gag-Pro was incorporated into particles at wild-
type levels, PR activation and maturation did not occur in this system. Other 
retroviral Gag proteins were not able to assemble in this system (106), 
suggesting that viruses that pre-assemble in the cytoplasm may have special 
assembly properties. One such property appears to be the “internal scaffold 
domain” (ISD), a multimerization domain located in MPMV p12 (between MA 
and CA). The ISD was required for MPMV assembly in extracts (105) and 
conferred onto HIV-1 Gag the ability to assemble in this system (104). 
Multimerization of the ISD is required for assembly to proceed (66). Consistent 
with the idea that the ISD is an adaptation to pericentriolar assembly, cellular 
assembly of ISD-mutant Gag can be rescued by re-targeting Gag to the 
plasma membrane (107).  
The second cell-free assembly system, for HIV-1 and other primate 
lentiviruses, requires a number of cellular co-factors. Full-length HIV-1 Gag 
mRNA (without Pol coding sequence) is added to wheat germ extract along 
with myristyl-CoA. Gag is translated and assembles into immature-like 
particles with a density similar to that of isolated cores (74). Assembly 
depends on myristylation of Gag, membrane association (membrane 
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fragments are present in the extract), ATP (74), and a cellular factor called 
HP68 or ABCE1, a putative RNAse L inhibitor (139). As in cells, assembly 
appears to proceed through a stepwise series of intermediates identified by 
sedimentation analysis, although the nature of these intermediates is not clear 
(74). The same system has been used for assembly of three related primate 
lentiviruses: human immunodeficiency virus type 2 (HIV-2) and two strains of 
simian immunodeficiency virus (SIV), SIVmac239, and SIVagm (31). This 
system would presumably be useful for the assembly of other myristylated 
Gag proteins. 
Cell-free assembly systems have two advantages for the study of 
retroviral assembly: they have fewer complicating factors than live cells but still 
support assembly of constructs that are difficult to purify due to low solubility 
(likely because low expression levels and the presence of cellular chaperones 
enhance solubility). However, cell extracts still contain a large number of host 
factors whose effects may be difficult to isolate, and the host factors in the 
systems used may be significantly different from those found in biologically 
relevant host cells; for example, wheat germ ABCE has only 71% amino acid 
identity to human ABCE1 (139). In addition, low expression levels lead to poor 
particle yields, so cell-free systems do not readily lend themselves to structural 
analyses. The cell-free systems described thus have some limitations for the 
study of retroviral assembly. 
 
Defined-component systems 
 Some of the limitations of cell-based and cell-free assembly systems 
can be overcome by the use of defined systems based on purified 
components. Such systems allow for the partial separation of the Gag-Gag, 
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Gag-lipid, and Gag-nucleic acid interactions required for assembly. They can 
be divided roughly by whether they are based on CA or on full-length Gag 
(thus producing mature- or immature-like particles); the latter require the 
addition of nucleic acid and occasionally other constituents, while the former 
usually do not. HIV-1 CA was the first retroviral Gag protein to be assembled 
in vitro. Under high salt concentrations (0.5-1.0 M) HIV-1 CA assembles into 
cylindrical or “tubular” particles (36, 45, 72), with occasional conical particles 
resembling classical HIV-1 cores; some CA mutants appear to favor the 
conical core morphology (45). Cryo-EM reconstructions of these tubes were 
among the first evidence for the NTD hexamer/CTD dimer model of the CA 
lattice (72). Other retroviral CA proteins have proven more refractory to 
assembly in vitro; RSV CA assembles poorly relative to HIV-1 and reports are 
conflicting regarding the optimal conditions (57, 64). A recently described RSV 
CA system involving high phosphate concentrations, which produces 
polyhedral particles resembling authentic cores rather than tubes, is more 
promising (98). These systems provide a valuable tool for isolating and 
examining the post-maturation steps of assembly. 
 In vitro assembly systems in which full-length or truncated Gag proteins 
assemble into immature-like particles have been developed for at least three 
retroviruses: MPMV, HIV-1, and RSV. MPMV was the first retrovirus to be 
assembled from purified protein, although the procedure was somewhat 
complex (65). Full-length Gag protein was expressed in Escherichia coli, in 
which it formed cytoplasmic structures resembling immature particles. The 
protein was poorly soluble and segregated to inclusion bodies, which also 
contained partially assembled structures. The inclusion bodies were isolated 
and solubilized with denaturing concentrations of urea. Renaturation by serial 
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dialysis produced spherical particles of an appropriate size and density for 
immature MPMV cores. The nucleic acid requirement was not examined, 
although it is reasonable to assume that the assembled structures within the 
inclusion bodies contained bacterial RNA that may have survived denaturation 
and reassembly. Overall, this system was inconvenient and remains 
noteworthy only as the first published example of immature retroviral VLPs 
assembled in vitro. 
More recently, a second MPMV system was developed to address 
some of these limitations (120). It was found that CA-NC protein with the N-
terminal proline deleted (so as to avoid formation of the β-hairpin and thus 
presumably retain an “immature” conformation) was highly soluble and readily 
purified from E. coli. This ΔProCANC protein could assemble into aggregates 
and interlocked spiral structures without nucleic acid or in the presence of 
short DNA oligonucleotides. Some regular virus-like particles were observed 
when longer (20-22 nt) oligonucleotides were used. Unlike immature cores, 
the aggregates migrated to the bottoms of isopycnic sucrose gradients, 
suggesting higher than normal density. By contrast, abundant regular particles 
were formed in the presence of long RNA (bacteriophage MS2 or E. coli 
rRNA). The corresponding CA-NC protein (with initial proline intact) formed 
planar sheets within E. coli cells (102) but could not be assembled in vitro 
(120). The effect of the initial proline on particle morphology is intriguing, as it 
suggests, for MPMV at least, that the absence of the β-hairpin alone may 
determine immature vs. mature lattice assembly. 
 The medical significance of HIV-1 has attracted a great deal of interest, 
and it is thus not surprising that a number of different systems have been 
developed for in vitro assembly of HIV-1 Gag. The oldest of these relies on 
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HIV-1 MA-CA-NC (the C-terminal p6 domain is deleted as it is otherwise 
removed by bacterial proteases) expressed in and purified from E. coli. Under 
physiological conditions, this protein assembles into spherical particles in the 
presence of nucleic acid. With nucleic acid alone, the particles formed are 
much smaller than authentic immature HIV-1 cores (25-30 nm vs. 100-120 
nm) (16); however, when inositol phosphates IP5 or IP6 are added to the 
reaction, the particles formed are similar in size and morphology to authentic 
cores (15). This is thus a three-component system, with Gag, nucleic acid, and 
inositol phosphates required to reconstitute correct immature VLPs. 
The inositol phosphate requirement is referable to the MA domain, as 
the second system, which involves a deletion of amino acids 16-99 of MA, 
produces normal-sized particles with nucleic acid alone (49). Radial density 
analysis showed that these particles are similar to authentic immature cores, 
with the exception of the absent MA domain. This ΔMA construct also has an 
intriguing pH sensitivity: when assembly is carried out at pH 8.0, the particles 
formed are all spherical, whereas at pH 6.5 the spheres are mixed with 
cylindrical particles (50). The nature of this pH-mediated switch is not clear, 
but a similar sensitivity is involved in monoclonal antibody binding to 
unassembled Gag, which revealed that epitopes on helices 3 and 6 of the CA 
NTD are exposed at pH 8.0 but occluded at pH 6.5. This suggests that the pH-
mediated morphology switch may be related to a conformational change in 
Gag (50).  
Two other groups have reported in vitro assembly of HIV-1 Gag with an 
intact MA domain and without the addition of inositol phosphates. The first of 
these systems uses a C-terminally 6His-tagged MA-CA-NC protein. It requires 
the addition of 5 mM MgCl2 and incubation at 37°C for efficient assembly, and 
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RNA was reported to be dispensable, although inclusion of rRNA accelerated 
assembly (85). Assembly efficiency was difficult to interpret and published 
TEM images suggest that the particle morphology was mildly defective. 
Assembly appears to proceed through a 60S intermediate (84). The utility of 
this system remains questionable due to inconsistencies in particle 
morphology. 
The last of the HIV-1 in vitro assembly systems employs an N-terminally 
His-tagged MA-CA-NC protein (52). Assembly is facilitated by increased 
temperature (37°C vs. 30°C vs. 23°C); while the addition of RNA reduces the 
temperature requirement, RNA is not required for assembly. Assembly 
efficiency was quantified by simple pelleting, which does not distinguish 
between particles and aggregates, rather than by equilibrium sedimentation 
which separates particles and aggregates. A pH-sensitive phenotype was 
reported, with spherical particles observed at pH 8.0 and cylindrical particles at 
pH 6.0. Particle morphology was subtly unusual in both cases: the spherical 
particles were packed into a two-dimensional sheet and many lacked the 
internal staining characteristics of the other preparations, while the cylindrical 
particles were indistinct. The same group has also reported in vitro assembly 
induced by disulfide-mediated dimerization via C-terminal cysteine residues in 
place of NC (4), but the particles shown were atypical and this system must 
currently be regarded as defective at best. The overall lack of consensus on 
the requirements for HIV-1 Gag assembly in vitro probably reflects the number 
of different researchers and Gag constructs involved. 
The third retrovirus for which an in vitro immature assembly system has 
been developed is RSV. The RSV in vitro assembly system is based on the 
truncated Gag construct ΔMBDΔPR, in which the globular membrane-binding  
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Figure 1.11: RSV in vitro assembly system. A. RSV Gag and ΔMBDΔPR 
construct used for in vitro assembly. B. TEM of spherical particles 
produced by ΔMBDΔPR. Scale bar represents 100 nm. C. TEM of 
cylindrical particles produced by similar construct lacking p10 domain. 
Scale bar represents 100 nm. Figure taken from reference (58). 
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domain of MA and the PR domain of Gag have been removed to improve 
solubility (17, 133) (Figure 1.11). The protein is stored at 500 mM NaCl and 
pH 8.0. For assembly, the protein is mixed with nucleic acid (10% by weight) 
and the assembly buffer adjusted to 100 mM NaCl and pH 6.5 by direct 
dilution or dialysis. Spherical virus-like particles (VLPs) assemble rapidly and 
efficiently under these conditions, with at least half of the protein assembling 
into particles. Particles are easily identified and examined by negative staining 
and transmission electron microscopy. The nucleic acid requirement is 
absolute, but a wide variety of nucleic acids (RNA, ssDNA, and dsDNA), as 
well as other polyanions such as heparin sulfate, support assembly (133). The 
smallest ssDNA oligonucleotide that allows assembly appears to be equivalent 
to two NC binding sites, suggesting that dimerization may be sufficient to 
initiate assembly in this system (79). Radial density analysis confirms that the 
particles produced are, allowing for protein truncation, identical to immature 
cores produced from cells (133). The requirement for the C-terminal 25 amino 
acids of p10 for spherical assembly was first identified in this system (58) 
(Figure 1.11). The RSV in vitro assembly system remains the most robust and 
possibly the most deeply studied of the in vitro immature assembly systems. 
While defined component assembly systems typically rely on non-
physiological protein concentrations and lack host factors that might facilitate 
assembly at lower concentrations, they do have advantages relative to the 
cell-based and cell-free systems previously described. Because these systems 
are based on purified Gag proteins, the effects of other components (e.g. 
nucleic acid, inositol phosphates, or, hypothetically, host cell proteins) can be 
readily examined. The absence of cell debris means that particle morphology 
can be examined by simple negative staining and TEM, rather than requiring 
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laborious thin-sectioning; this makes in vitro assembly a useful screening 
procedure for Gag mutations that may cause assembly defects. The isolation 
of assembly from other processes involved in virus-like particle production is 
useful when trying to determine when a particular defect in particle production 
occurs. Finally, the large amounts of protein produced in E. coli, and the purity 
of the particles or assembly intermediates produced, make these systems 
suitable for in depth structural study. 
 
ONGOING QUESTIONS IN RSV ASSEMBLY 
 
Relevance of extended NTD structure to immature assembly 
The mechanism by which the C-terminal 25 amino acids of RSV p10 
promote spherical assembly was not known at the inception of the work 
presented in this thesis. A possible clue to the function of this sequence came 
with the publication of a crystal structure of the N-terminal domain of RSV CA 
with a 25 amino acid upstream extension (91). This extended NTD protein 
crystallized as a dimer with an extensive interface between p10 and the NTD 
(Figure 1.7). The correspondence between this structure and the HIV-1 
conformational switch is intriguing. In the latter, switching from the sphere-
promoting to the tube-promoting pH occludes epitopes on helix 3 and helix 6 
of the N-terminal domain of CA (50). The analogous helices in the RSV NTD 
are involved in the extended NTD dimer interface. However, modeling this 
structure into a virus particle requires significant bending of CA at the flexible 
linker (91), whereas radial density studies on spherical VLPs assembled in 
vitro and on immature cores imply that Gag is extended with a linear array of 
domains (133). In addition, a random mutagenesis of the critical region of p10 
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produced normal (spherical) and cylindrical particles in E. coli lysates, as well 
as proteins that failed to assemble, but there was no discernable pattern to the 
assembly results, let alone any correspondence to the crystal structure (58). 
Therefore, the biological significance of this structure was in doubt, and the 
mechanism of the p10 morphology switch remained unknown at the inception 
of this thesis research. 
The p10 domain of RSV Gag is also implicated in nuclear export of Gag 
in cells. In cultured cells, an MA-GFP fusion protein, unlike the Gag-GFP 
fusion, localizes to the nucleus, while extension through p10 restores 
cytoplasmic localization. This implies that there is a nuclear export signal 
(NES) within p10. The NES was subsequently localized to amino acids 24-57, 
overlapping with the 25 residues required for spherical assembly, amino acids 
33-57. This NES was found to be dependent on the cellular nuclear export 
factor CRM1 based on nuclear accumulation of Gag following treatment with 
leptomycin B, an inhibitor of the CRM1-dependent nuclear export pathway. 
CRM1-dependent nuclear export sequences are typically leucine-rich, and 
there is such a motif (LXXWXXVXXXL) within the last 25 amino acids of p10. 
Some mutant RSV virus constructs that package only a single copy of the viral 
genome (instead of the dimeric genome required for infectivity) fail to 
accumulate in the nucleus when treated with LMB, and it is hypothesized that 
nuclear transit is required for packaging of a dimeric genome (111). 
Unfortunately, the dual requirement for these residues for nuclear export and 
assembly has complicated analysis of both functions (112). As part of my 
thesis work, I performed a systematic investigation of the assembly function of 
the last 25 amino acids of RSV p10, using the in vitro assembly system to 
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bypass the NES function, in order to elucidate both the assembly function of 
this critical region. 
 
Initiation of assembly by dimerization 
Dimerization is a critical step in retroviral assembly in cells, as 
demonstrated by the production of particles when the NC domain of HIV-1 is 
replaced by a dimeric “leucine zipper” (1, 137); the same result is seen for 
RSV in a baculovirus/Sf9 expression system, with normal particle morphology 
confirmed by electron microscopy (56). Dimerization is also critical in vitro: 
while diverse nucleic acids support assembly, there is a minimum size that 
corresponds to two NC-binding sites (79). Both dimerizing and trimerizing 
leucine zippers have been used to drive HIV-1 assembly in vitro (Alan Rein, 
personal communication). Replacement of HIV-1 NC with a single cysteine 
residue that is oxidized to form disulfide-mediated dimers also leads to 
assembly in vitro (4). 
No artificial dimerization system has proven successful for RSV 
assembly in vitro. This may be due to a functional element in RSV Gag, 
recently identified by this laboratory, which spans the C-terminal tail of CA, the 
SP domain, and the first four amino acids of NC. We have seen that disruption 
of this sequence by insertion or substitution produces tubular Gag particles in 
the baculovirus expression system in insect cells(60); parallel constructs fail to 
assemble in vitro (59). All of the prior attempts to introduce artificial 
dimerization domains have involved fusing the domain in question directly to 
the C-terminus of SP, removing the last four amino acids of the CA-SP-NC 
element. While such a fusion formed spherical particles in the baculovirus 
expression system, it is possible that the degree of overexpression inherent to 
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that system masks some subtle defect in assembly. An in vitro assembly 
system driven by artificial dimerization would help to clarify the roles of 
dimerization and of the CA-SP-NC element in RSV assembly. 
 
THESIS OUTLINE 
 In this dissertation, I describe a series of experiments undertaken to 
explore the roles of the p10 domain and of dimerization in RSV assembly. As 
related in Chapter 3, I began by performing a systematic mutagenesis of the 
last 25 amino acids of p10 in which I identified six amino acids that abrogated 
in vitro assembly when individually mutated to alanine. Of these six amino 
acids, five made side chain contacts with the CA domain in the extended NTD 
structure, while 14 of the 15 non-alanine amino acids that were dispensable 
for assembly made no such contact. In addition, mutation of two amino acids 
in helix 3 of CA that made hydrogen bonds with the p10 domain in the 
extended NTD structure also abrogated assembly. To determine whether the 
p10-CA interface actually existed in virus-like particles, I introduced a pair of 
cysteine residues in place of E51 of p10 and T20 of CA. These exogenous 
cysteines were predicted by the extended NTD structure to form a disulfide 
bond across the p10-CA interface. I then developed an in vitro oxidation 
protocol that allowed me to demonstrate specific p10-CA cross-linking in VLPs 
assembled in vitro and in cells. The product of cross-linking across the 
interface was not a dimer, as predicted by the extended NTD structure, but a 
high molecular weight complex. I isolated the high MW complex by 
sedimentation and used partial reduction to demonstrate that it was in fact a 
hexamer. Collaboration with a molecular modeling group produced models of 
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the mature and immature RSV NTD hexamers which agree with recently 
obtained electron cryotomography data for immature retroviral particles. 
 As described in Chapter 4, I next attempted to develop a system for 
assembling RSV Gag by artificial dimerization, employing a variety of Gag-
leucine zipper fusion proteins as well as an FKBP-based inducible 
dimerization system developed by Ariad Pharmaceuticals. I first took a Gag-
leucine zipper fusion that had produced morphologically normal particles in a 
baculovirus overexpression system and expressed it in avian cells. This 
construct was able to bud from avian cells but did not do so reproducibly. I 
then attempted to perform in vitro assembly of Gag-leucine zipper fusion 
proteins using heterodimeric zipper pairs and recently obtained knowledge of 
an upstream assembly element to improve on previous failed attempts. Both 
homo- and heterodimeric leucine zipper fusions failed to dimerize (by 
sedimentation analysis) or assemble (by TEM) in vitro. Attempts to assemble 
Gag-FKBP fusion proteins in cells were also unsuccessful: neither budding 
from cells nor sedimentation in vitro showed any response to the dimerizing 
reagent. I was not able to determine whether this was due to a failure of the 
protein to dimerize or to dimerization in the absence of the reagent. Future 
directions for this line of research are described in Chapter Five. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
DNA constructs for p10 mutagenesis and cross-linking studies 
 The pET3xc.ΔMBDΔPR plasmid has been described previously (17). 
pET3xc.ΔMBDΔPR (ΔBlpI) was generated by partially digesting ΔMBDΔPR 
with BlpI, gel-purifying single-cut plasmid, blunting the ends with Taq 
polymerase, and ligating to destroy the site; clones were screened by 
XhoI/BlpI double digestion to identify one with a unique BlpI site in CA. This 
step destroyed a BlpI site in the vector backbone and left a unique BlpI site in 
the NTD of CA. pET3xc. ΔMBD(-6C) is an unpublished plasmid (constructed 
by May Ma (77)) in which the six cysteines in NC were replaced by alanine by 
two-step PCR. ΔMBD(-11C) was made by replacing the XhoI/FseI fragment of 
ΔMBD(-6C) with a PCR product in which the five cysteines upstream of p10 
were mutated to serine by two rounds of two-step PCR. Mutations involving 
P38, G39, or P40 of p10 were made by replacing the XhoI/BlpI fragment of 
ΔMBDΔPR(ΔBlpI) with two-step PCR products containing the desired 
mutation; the remainder of the alanine and GSGSG substitutions, and E51C, 
T20C, and E51C/T20C, were made by replacing the FseI/BlpI fragments of 
ΔMBDΔPR(ΔBlpI) with two-step PCR products containing the desired 
mutation(s). E51C(-11C), T20C(-11C), and E51C/T20C(-11C) were made by 
replacing the FseI/SacII fragment of ΔMBD(-11C) with the analogous fragment 
from the analogous ΔMBDΔPR(ΔBlpI) constructs. TWCC(-11C) was made by 
replacing the FseI/SacII fragment from ΔMBD(-11C) with a two-step PCR 
product amplified from E51C/T20C(-11C). P38CC(-11C) was made by 
replacing the XhoI/FseI fragment of T20C(-11C) with a two-step PCR product 
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that used ΔMBD(-11C) as a template. E51Cf was made by replacing the 
FseI/BlpI fragment of ΔMBDΔPR(BlpI) with a two-step PCR product using 
p10(58-62)f as a template. E51C-f-T20C was made by replacing the FseI/BlpI 
fragment of ΔMBDΔPR(ΔBlpI) with a 2-step PCR product using E51Cf as a 
template to make E51C-f-T20C. Finally, E51C-f-T20C(-11C) was made by 
replacing the FseI/SacII fragment of ΔMBD(-11C) with that from E51C-f-T20C. 
 The protease pET11c.ePR(C113S) was made by replacing the AvrII 
fragment of pET11c.his-ePR (110) with two annealed oligonucleotides. 
 pQCXIP.SMGagΔPR(-11C) was made by replacing the XhoI-PacI 
fragment of the unpublished plasmid pQCXIP.SMGag (constructed by 
Amanda Dalton) with a PCR product amplified from ΔMBD(-11C). The other 
cell expression constructs were then made by replacing the XhoI/BlpI fragment 
of SMGagΔPR(-11C) with that from the analogous E. coli expression vector. 
 All PCR-derived fragments and cloning sites were confirmed by 
sequencing. 
 
DNA constructs for dimerization studies 
 The pCMV.MA-CA-LZ and pCMV.MA-CA constructs were made by 
replacing the BglII-NotI fragment of pEGFP.N2 (Clontech) with a double-
stranded oligonucleotide containing a KpnI site. The SacI/KpnI fragment of the 
intermediate plasmid was replaced with the SacI/KpnI fragment from pFB.MA-
CA-Zip or pFB.MA-CA (56). The pCMV.MA-CA-FKBP plasmid was made by 
replacing the SacII/KpnI fragment of pCMV.Gag-D37S (69) with a PCR 
product amplified from pC4-Fv1E (Ariad Pharmaceuticals). The forward primer 
was extended at the 5’ end to contain the Gag sequence from the SacII site 
through nt 1464 of Gag so that the SP/NC border of Gag was fused to amino 
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acid 5 of Fv1. The remainder of the Fv1 domain through the stop codon was 
included in the PCR product. 
 The in vitro dimerization constructs were made by inserting an HpaI site 
into pET3xc. ΔMBDΔPR(ΔBlpI) at nt 1227 of the Gag sequence to make 
pET3xc. ΔMBD-NC4-HpaI. This required two conservative nucleotide 
substitutions and resulted in HpaI cutting at the NC+4 position without 
changing any amino acids. The HpaI/KpnI fragment of pET3xc. ΔMBD-NC4-
HpaI was replaced with primer extension products to generate pET3xc. 
ΔMBD-zip, pEt3xc. ΔMBD-Kzip, pET3xc. ΔMBD-Zip3, and pET3xc. ΔMBD-
Zip12. The HpaI/KpnI fragment was replaced with a PCR product amplified 
from pC4-Fv1E to generate pET3xc. ΔMBD-NC4-fFKBP, in which amino acid 4 
of NC was fused to a GSGSG linker followed by amino acid 6 of Fv1E (amino 
acid 5 of Fv1E is a glycine). A 3C protease cleavage site (EVLFQ/GP) followed 
by a 6-His tag was included at the C-terminus of the Fv1E sequence.  
 
Protein purification 
ΔMBDΔPR and derivatives containing an NC domain were expressed 
and purified as previously described (133) with the following changes: after 
ammonium sulfate precipitation, the protein was further purified by cation 
exchange chromatography using an Amersham AKTA prime FPLC system. 
The ammonium sulfate pellet was dissolved in 10 mL 20 mM Tris pH 8.0, 
bound to an Amersham SP FPLC column in 20 mM Tris pH 8.0, 100 mM NaCl 
and eluted with 20mM Tris pH 8.0 and 500 mM NaCl in a single step. DEAE 
and phosphocellulose purification and dialysis steps were omitted. Protein 
concentration was assayed using Advanced Protein Assay reagent 
(Cytoskeleton, Inc.) and adjusted to 5 mg/mL by centrifugal filtration (5000 
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MWCO) or dilution with 20 mM Tris pH 8.0 and 500 mL NaCl. DTT (10 mM) 
was added to proteins which were not to be used for cross-linking studies. 
ΔMBDΔPR proteins lacking an NC domain were purified as follows. 
ΔMBD-Kzip had a strongly positively-charged C-terminal domain and was 
purified as though it contained NC. ΔMBD-bzip, ΔMBD-Zip3, and ΔMBD-Zip12 
were purified similarly to ΔMBDΔPR through the ammonium sulfate 
precipitation step. The ammonium sulfate pellet was resuspended in 5 mL 20 
mM Tris pH 8.0, 100 mM NaCl and allowed to flow through both DEAE and 
phosphocellulose columns (~2 mL) followed by a 5 mL wash with 20 mM Tris 
pH 8.0, 100 mM NaCl. The flowthrough and washes were pooled and dialyzed 
4 hours to overnight against 20 mM Tris pH 8.0, 500 mM NaCl, and 10 mM 
DTT. Proteins were concentrated to 5 mg/mL by centrifugal filtration (5000 
MWCO). Protein concentration assays and storage conditions were the same 
as for ΔMBDΔPR. 
ΔMBD-NC4-fFKBP was purified by nickel affinity chromatography. 
Protein was expressed in E. coli, the cells were lysed, and the lysates were 
cleared as for ΔMBDΔPR. The ultracentrifugation supernatant was incubated 
with 2.5 mL 50% Ni-NTA agarose (Qiagen) rocking for 1 hour at 4°C. The 
beads were washed with 2 X 10 mL 20 mM Tris pH 8.0, 500 mM NaCl, and 20 
mM imidazole. The protein was eluted with 4 X 1 mL 20 mM Tris pH 8.0, 500 
mM NaCl, and 250 mM imidazole. The majority of the protein was contained in 
the second elution fractions. This fraction was dialyzed overnight against 20 
mM Tris pH 8.0, 500 mM NaCl, and 10 mM DTT. Protein concentration assays 
and storage conditions were the same as for ΔMBDΔPR. 
RSV ePR and ePR (C113S) were purified as previously published (110) 
with minor modifications. Following sonication, the proteins were insoluble and 
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were purified from inclusion bodies. Inclusion bodies were collected by 
centrifugation at 10,000 x g for 15 minutes, resuspended and re-pelleted twice 
with 20mM Tris pH 7.5, 2M urea, 2% Triton X-100, 10 mM DTT, 1 mM PMSF 
and a third time with the same buffer without urea or Triton X-100, and 
pelleted again. The pellet was dissolved in 10 mL 20 mM Tris pH 7.5, 7 M 
urea, and 10% glycerol and stirred for 30 minutes at room temperature. 
Insoluble material was pelleted (10 min at 10K rpm in SA-600) and discarded. 
The supernatant was dialyzed overnight against 20 mM Tris pH 7.5, 20 mM 
NaCl, 1 M urea, and 10% glycerol. Precipitated protein was removed by 
centrifugation (10 min at 10K rpm in SA-600). The supernatant was incubated 
with 2.5 mL 50%  Ni-NTA slurry rocking for 1 hour at 4°C. The beads were 
washed with 2 X 10 mL 20 mM Tris pH 8.0, 20 mM NaCl, 1M urea, 20 mM 
imidazole, 10 mM DTT. The protein was eluted with 4 X 1 mL elution buffer 
(20 mM Tris pH 8.0, 20 mM NaCl, 1 M urea, 250 mM imidazole, 10 mM DTT). 
The majority of the protein was found in the second elution fraction. This 
protein fraction was dialyzed overnight against 20 mM Tris pH 6.0, 100 mM 
NaCl, 1% glycerol, and 0.4 M urea. Precipitated protein was removed as 
previously described. The supernatant was incubated at 37°C for 5 h to 
overnight to allow self-cleavage of the 6-His tag. The reaction was dialyzed 
against the same buffer to remove the cleaved His tag and insoluble material 
was removed as previously described. The protein concentration was assayed 
by UV spectroscopy and the protein was stored at -80° C. 
 
In vitro assembly and electron microscopy 
Proteins containing NC were assembled by dilution to 1 mg/mL in 50 
mM MES pH 6.0 or 6.5 with or without 50 μM DTT, addition of 10% wt/wt 
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ssDNA (GT50, an oligonucleotide with 25 GT repeats (133)), gentle mixing, 
and incubation at room temperature for 15 minutes. Proteins without NC were 
diluted to 1 mg/mL in 50 mM MES pH 6.5 without GT50, with the exception of 
ΔMBD-Kzip, which was assembled with 10% GT50. ΔMBD-NC4-fFKBP was 
assembled by diluting to 1 mg/mL with 50 mM MES pH 6.5 and adding a 
stoichiometric amount (10 μM) of AP20187. 
  Assembly reactions were spotted onto carbon-Formvar-coated grids 
and stained with 2% uranyl acetate (pH 5.0). The particles were visualized on 
a Morgagni 268 transmission electron microscope. Proteins scored as 
assembly-competent yielded many particles visible in a single field. Proteins 
scored as assembly-incompetent yielded no regular particles. 
 
Centrifugation 
Equilibrium centrifugation was performed on 10-60% (wt/wt) sucrose 
gradients in assembly buffer (50 mM MES pH 6.5 and 100 mM NaCl). 
Gradients were spun in an SW60 rotor at 50,000 rpm for 4 h at 4°C. Fractions 
containing VLPs were collected from the gradient and their densities 
measured with a refractometer. The VLP fractions were diluted 1:5 with 
assembly buffer and the VLPs were pelleted by spinning in a microfuge at 
16,000 x g for 30 min at 4°C.  
Rate-zonal centrifugation was performed on 10-30% wt/wt sucrose 
gradients. The gradients were made in 50 mM MES pH 6.5, 500 mM NaCl, 2 
M urea for the cross-linking experiments and in 50 mM Tris pH 8.0, 100 mM 
NaCl for the dimerization assays. Gradients were spun in an SW60 rotor at 
50,000 rpm for 24h at 4°C. 
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Oxidation and PR digestion 
 Particles were resuspended in assembly buffer with or without 10 μM 
DTT. Resuspended particles were oxidized with copper phenanthroline (60 μM 
CuSO4, 267 μM o-phenanthroline), mixed by vortexing for approximately five 
seconds, and immediately quenched with 20 mM iodoacetamide and 3.7 mM 
Neocuproine (Sigma). In vitro PR digestion was carried out as previously 
described (110). In brief, reactions were adjusted to 100 mM MES pH 6.5, 700 
mM NaCl, 0.7 mM EDTA, and 5.3% glycerol. Prior to digestion, DTT to 15 mM 
was added to reduced samples and fresh iodoacetamide was added to 
oxidized samples. A cysteine-lacking mutant of RSV PR (PR C113S) purified 
from E. coli was added at 2 μg PR/10 μg ΔMBDΔPR. (Wild-type PR is inactive 
in the presence of iodoacetamide.) Reactions were incubated at 37°C for 16h. 
Fresh iodoacetamide was added to oxidized samples immediately prior to 
SDS-PAGE. 
 
Cell culture, transfection, and transduction 
DF1 (chicken embryonic fibroblast) cells were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum (or 5% 
fetal bovine serum and 5% NuSerum (BD Biosciences)), 1% heat-inactivated 
chick serum, standard vitamins, L-glutamine, penicillin and streptomycin.  
 For MA-CA-LZ and MA-CA-FKBP experiments, cells were maintained 
in 60 mm dishes and transfected with 4 μL FuGENE transfection reagent 
(Roche) and 1 μg DNA per dish.  
For cross-linking experiments, stable cell lines expressing Gag proteins 
were created by transduction with virus derived from Phoenix cells transfected 
with pQCXIP.SMGagΔPR(-11C) and related constructs. Phoenix cells were 
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transfected using FuGENE 6 (Roche). 24 hours post-transfection, the medium 
from the Phoenix cells was collected, filtered (sterile 0.45 μM syringe filters), 
mixed 1:1 with fresh medium and applied to DF1 cells. If DF1 cells appeared 
vacuolated or otherwise unhealthy, the medium was replaced with 100% fresh 
DMEM after 12 hours. This infection procedure was repeated daily until the 
Phoenix cells began lifting off of the dish or the DF1 cells became confluent (2-
3 days). Transduced cells were selected with 2 μg/mL puromycin until 
widespread apoptosis was evident (~3 days). 
 
35S labeling and immunoprecipitation 
 24-48 hours post-transfection, cells were labeled with 100 mCi 35S 
methionine/cysteine in 500 μL methionine/cysteine-free DMEM per 60 mm 
dish for 15 minutes. Separate dishes were labeled for each construct at each 
planned timepoint. After the 15 minute labeling period, cells were rinsed X 3 
with PBS and 2 mL DMEM was added to each dish for the chase period. 
 At the designated timepoints, medium was removed and virus-like 
particles were collected as described below. Cells were rinsed with PBS and 
incubated with 0.5 mL RIPA buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1% 
deoxycholic acid (sodium salt), 1% Triton X-100, 1 mM PMSF) for ten minutes 
on ice. Dishes were scraped with rubber policeman or cell lifter, lysates were 
transferred to 1.5 mL Eppendorf tubes, and dishes were washed with an 
additional 0.5 mL RIPA buffer which was combined with the lysates. Lysates 
were spun at 10,000 X g (11,000 rpm in microcentrifuge) for five minutes to 
pellet the nuclei. The supernatants were transferred to new tubes and mixed 
with 1 μL each rabbit anti-RSV MAp10 and rabbit anti-RSV CA serum and 
incubated rotating 1-16 hours at 4°C. 35 μL Protein A-Sepharose beads (1:1 
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slurry) was added to each lysates and incubated rotating 1-2 h at 4°C. The 
beads were washed with 3 X 1 mL RIPA buffer with 15 minute incubations 
between each wash. Finally, the beads were boiled for ten minutes with 40 μL 
SDS-PAGE sample buffer. 
 
Virus-like particle collection from cell culture medium 
 Medium was spun at 1500 X g (~4000 rpm in a microfuge or ~3000 rpm 
in a clinical centrifuge) for five minutes to pre-clear. Supernatants were loaded 
into polyallomer TL 100.4 tubes. For some 35S labeling experiments, purified 
unlabeled ALV virus was added as a carrier. Approximately 0.5 mL 15% 
sucrose (wt/wt) in virion suspension buffer (VSB) (20mM Tris pH 7.5, 100 mM 
NaCl, 1mM EDTA) was added to the bottom of each tube as a cushion. 
Samples were spun at 70K rpm for 20 minutes in the TL100.4 rotor. Medium 
was aspirated off and the sides of the tube were rinsed with PBS or VSB 
before the sucrose cushion was aspirated off as well. 
 
Autoradiography 
 For 35S labeling experiments, pelleted VLPs were resuspended in 
SDS-PAGE sample buffer and 100% of both immunoprecipitation and pelleted 
VLP samples were loaded for SDS-PAGE. Following electrophoresis, the gels 
were dried and exposed to a 35S phosphor screen for 24-48 hours (or longer 
as needed). The screen was read using a STORM 860 phosphorimager 
(Molecular Dynamics) and gel files were analyzed using ImageQuant software. 
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Immunoblotting  
For cross-linking experiments, confluent transduced cells were split 1:8 
and cells and medium were harvested 3 days later. Cells were trypsinized, 
rinsed with PBS, and resuspended directly in SDS-PAGE sample buffer. 1% of 
each cell lysate was loaded for SDS-PAGE. VLPs were collected from the 
medium as described above. For cross-linking experiments, pellets were 
resuspended in VSB plus 20 mM iodoacetamide and permeabilized with 
0.01% Triton X-100 in the same buffer. PR digestion was carried out as 
previously described. 10% of each sample was loaded for SDS-PAGE. 
Following SDS-PAGE, gels were transferred to nitrocellulose membrane (30 
minutes- hour at 100 V, 20% methanol in transfer buffer). For cross-linking 
experiments, the membrane was incubated shaking in “block” (10% non-fat 
dried milk in TBST (20 mM Tris pH 8.0, 137 mM NaCl, 0.1% Tween-20)) for 16 
hours at 4°C. The membrane was washed 2 X five minutes with TBST and 
incubated with the primary antibody (polyclonal rabbit anti-RSV CA serum 
1:1000 in block) for one hour at room temperature. The membrane was 
washed for ten minutes with block and 2 X ten minutes with TBST and 
incubated with the secondary antibody (monoclonal anti-rabbit IgG conjugated 
to alkaline phosphatase (Sigma), 1:30,000 in block) for one hour at room 
temperature. The membrane was washed 3 X twenty minutes in TBST. ECF 
reagent (Amersham) was applied to the membrane, and the fluorescence was 
immediately read using the Storm 860 phosphorimager (Molecular Dynamics) 
on the blue fluorescence setting. The gel files were analyzed using 
ImageQuant software. 
For FKBP budding experiments, cells and medium were harvested 24 
hours post-transfection. VLPs were collected as described above. Cells and 
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VLP pellets were resuspended directly in SDS-PAGE sample buffer and 1% of 
lysates and 10% of VLP pellets were loaded for SDS-PAGE. Immunoblotting 
was performed as described above with the following modifications. The first 
incubation of the membrane in block was performed for one hour at room 
temperature. The primary antibody was diluted in TBST rather than in block 
and hybridization was performed for 16 hours at 4°C. The secondary antibody 
was also diluted in TBST rather than in block. 
 
Molecular modeling 
Molecular modeling of the RSV NTD hexamers was performed by Paul 
Murray (Columbia University). The structures for the MLV CA NTD hexamer 
(PDB code 1U7K, (88)) and the RSV extended NTD dimer (PDB code 1P7N, 
(91)) were used to model the mature RSV CA NTD hexamer. The protein 
secondary structure prediction programs, PSIPRED (82), 3D-PSSM (61), and 
Scratch (97) predict a β-hairpin in residues 1-15 of RSV CA NTD, as seen in 
the mature RSV CA NTD structure (PDB code 1EM9, (64)). Consequently, the 
modeling program Nest (96) was used to construct a composite model of RSV 
CA NTD in which residues 1-21 were modeled after 1U7K and 22-144 were 
modeled after 1P7N. The resulting mature monomer model was then 
structurally super-imposed, using the Combinatorial Extension (CE) server 
(115), on each sub-unit (A-F) of 1U7K, the mature MLV CA NTD hexamer, 
thus yielding a mature model of the RSV CA NTD hexamer. 
  The same structures (1U7K & 1P7N) were used to construct an 
immature model of the RSV CA NTD hexamer. As opposed to the mature CA, 
immature CA is not cleaved between Met0 and Pro1; i.e., the upstream p10 
helix is joined to and free to interact with CA. In order to model the immature 
 59
hexamer, the a-B inter-molecular pair of p10-CA NTD from 1P7N was excised. 
The p10 half, “a”, was cut after CA Thr6; therefore, p10 comprises Pro-24 to 
Thr6 of “a”. The CA NTD half, “B”, was cut before Leu14; therefore, CA NTD 
comprises Leu14 to Ala144 of “B”. The “a-B” pair was then structurally super-
imposed, using CE, on each sub-unit of 1U7K. With the “p10” region added in, 
there was significant structural overlap between the sub-units of the immature 
hexamer. In order to relieve this overlap, each sub-unit was radially moved 
away from the center of the hexamer until there was no structural overlap. The 
program Loopy (96) was used to model in the missing segment between 
residues Thr6 and Leu14. This segment was modeled such that each p10 
region is joined to the next CA NTD of the hexamer, moving clock-wise. 
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CHAPTER 3 
RELEVANCE OF THE EXTENDED NTD STRUCTURE TO IMMATURE 
ASSEMBLY1
 
INTRODUCTION 
 
Rous Sarcoma Virus is a well-studied avian virus that is frequently 
employed as a model retrovirus. Among the advantages of RSV as a model is 
a robust in vitro system for immature assembly. A truncated RSV Gag termed 
ΔMBDΔPR (Figure 1.11) can be purified and assembled in vitro into spherical 
virus-like particles (VLPs) that are similar in shape, size, and radial density 
profile to immature cores produced from cells (17, 133). Deletion of p10, the 
Gag domain immediately upstream of CA, produces cylindrical particles (17); 
as purified HIV-1 CA assembles into cylinders in vitro (36, 45), cylindrical 
morphology is considered indicative of a mature (or mature-like) CA lattice. 
Internal and N-terminal deletions of p10 give the same result, so the 
morphology change cannot be ascribed to NTD β-hairpin formation alone. The 
spherical assembly determinant was further localized to the C-terminal 25 
amino acids of p10, both in vitro (58) and in a baculovirus expression system 
(56). The same sequence also contains a CRM-1-dependent nuclear export 
signal (NES) required for proper intracellular trafficking of Gag and for viral 
genome packaging (13, 111-113); the significance of this dual function of p10 
is unknown. 
                                                 
1 Expanded from Phillips, J.M., P.S. Murray, D.Murray and V.M. Vogt. 2008. A molecular 
switch required for retrovirus assembly participates in the hexagonal immature lattice. Embo J 
27:1411-1420. 
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When the RSV NTD was extended N-terminally to include the 25 amino 
acids immediately upstream (the last 25 amino acids of p10), it crystallized as 
an anti-parallel dimer with an extensive p10-CA interface (91) (PDB ID: 1P7N) 
(Figure 1.7). The extended NTD monomer is similar in structure to the mature 
NTD previously characterized by NMR and crystallography (19, 64, 91) but 
lacks the N-terminal β-hairpin of CA, which is destabilized when proline 1 of 
CA is not free to form the salt bridge with aspartate 52 in helix 3 (Figure 3.1). 
The dimer interface includes residues in a short α-helix in the p10 segment. 
Because of the anti-parallel arrangement of the NTDs, the extended NTD 
dimer presumably cannot be a subunit of an NTD hexamer and therefore is 
probably not found in the immature virus particle. In addition, assembly results 
from a random mutagenesis of the critical region of p10 did not obviously 
correspond to the structure (58). That said, the requirement of the same 25 
amino acids of p10 for both spherical virus particle morphology and the 
extended NTD dimer interface suggests that the p10-CA contacts in the dimer 
interface may have some relevance to immature assembly. 
 
RESULTS 
 
Systematic mutagenesis suggests extended NTD structure is relevant to 
immature assembly 
   I sought to determine whether the extended NTD structure was relevant 
to immature assembly using the RSV in vitro assembly system. I chose the in 
vitro system for this study for two reasons. First, the in vitro system enabled 
me to study the assembly function(s) of the C-terminal 25 amino acids of p10 
without regard to the overlapping NES discussed above and in Chapter 1. 
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Figure 3.1: Extended NTD is largely similar to the mature NTD. The 
mature NTD backbone (64) is in green. The extended NTD is in gold (CA 
residues) and red (p10 residues). The backbones overlap well except in 
the β-hairpin region, which is unfolded in the extended NTD structure. 
Figure taken from reference (91). 
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Second, examination of in vitro assembled particle morphology by TEM 
requires only negative staining, a process that is faster and simpler than 
fixation and thin-sectioning of particle-producing cells. Because the results of a 
previous random mutagenesis of the region were inconclusive (58), I first 
performed a systematic alanine mutagenesis in the context of the in vitro 
assembly construct ΔMBDΔPR (Figure 1.11). The critical 25 amino acid 
region was divided into five segments of five amino acids and each segment 
was mutated in turn to either AAAAA or GSGSG. The resulting constructs 
were expressed in Escherichia coli, purified, assembled in vitro as described in 
Chapter Two, and screened for assembly by negative staining and TEM. I 
performed two independent expressions and purifications of each protein. All 
proteins showed a consistent phenotype, yielding either abundant regular 
spherical particles or no regular particles. Segments of five amino acids that 
could be mutated to AAAAA or to GSGSG without affecting assembly were 
scored as dispensable for assembly. Segments of five amino acids for which 
mutation to both AAAAA and GSGSG prevented assembly were subdivided 
into smaller alanine substitutions until all individual amino acids required for 
assembly were identified. The four endogenous alanine residues were not 
individually mutated.  
The results of this mutagenesis (Table 3.1) showed that the last 10 
amino acids of the critical region allowed extensive substitution, while the first 
15 amino acids of the critical region contained a mix of required and 
dispensable amino acids. While the last 10 amino acids were dispensable for 
assembly, the mutagenesis results showed that they were not all functionally 
equivalent in this assembly assay: the most C-terminal segment (residues 58-
62; PVVAM) tolerated mutation to GSGSG but not to AAAAA, while the  
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 Table 3.1: Constructs used to test p10-NTD interface. “A” indicates that 
the indicated residues were mutated to alanine, “f” that the indicated 
residues were mutated to GSGSG. 
p10 mutants Assembly 
phenotype 
(38-42)A - 
(43-47)A - 
(48-52)A - 
(53-57)A + 
(58-62)A - 
(38-42)f - 
(43-47)f - 
(48-52)f - 
(53-57)f + 
(58-62)f + 
(38-39)A + 
P40A + 
L42A - 
T43A - 
D44A - 
W45A - 
(47-48)A - 
R47A + 
V48A - 
(49-50)A + 
(51-52)A - 
E51A + 
L52A - 
CA mutants  
D52A - 
N55A - 
Combination mutants  
(T43, W45)A/(53-57)A - 
(T43, W45)A/(58-62)f - 
(T43,W45,V48,L52)A - 
(T43,W45)A/N55A - 
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 preceding segment (residues 53-57; ASTGP) tolerated both mutations. These 
results suggested that while none of the side chains in the last 10 amino acids 
of p10 is required for assembly, there are some sequence constraints on the 
final five amino acids. By contrast, some of the first fifteen amino acids of p10 
appear to make specific side chain contacts that are required for assembly. 
There are two amino acids in the NTD that make predicted side chain 
hydrogen bonds across the dimer interface in the extended NTD structure, CA 
D52 and N55, both of which are located in helix 3 of CA. Mutation of either of 
these to alanine also abrogated assembly (Table 3.1). In addition, I attempted 
to obtain cylindrical particles by making various combinations of p10 and NTD 
mutations; unfortunately, none of these constructs produced any regular 
particles (Table 3.1). 
Comparison of the mutagenesis results with the published amino acid 
contacts in the extended NTD interface (91) revealed a striking pattern. Of the 
six amino acids in p10 whose side chains contacted the NTD in the structure, 
five were required for assembly and only one (E51 in the p10 helix) was 
dispensable (Figure 3.2). Similarly, of the fifteen non-alanine amino acids 
whose side chains were not involved in the interface, fourteen were 
dispensable and only one (D44 upstream of the p10 helix) was required. 
These results strongly support the hypothesis that the p10-CA interface in the 
extended NTD structure is involved in immature assembly.  
 
The p10 domain of Gag can be cross-linked to CA via disulfide bonds 
The ability of the E51A mutant to assemble despite altering a side chain 
contact with the NTD offered an opportunity to use disulfide cross-linking to  
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Figure 3.2: In vitro assembly results correlate with side chain contacts in 
extended NTD structure. C-terminal 25 amino acids of RSV p10 domain 
with mutagenesis results. “Side chain contact” indicates those amino 
acid residues whose side chains contact the CA domain in the extended 
NTD structure. “Required for assembly” indicates those amino acid 
residues which, when changed to alanine, abrogate assembly in vitro. 
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test for the presence of the extended NTD p10-CA interface in assembled 
virus particles. The Swiss-PDBViewer program (51) predicted a disulfide bond 
when E51 in the p10 helix and the residue it contacts in CA, T20 in helix 1, 
were mutated to cysteines (Figure 3.3) in the context of the extended NTD 
structure. Therefore, the p10-CA interface depicted in the 25NTD structure 
could be detected in virus particles by mutating these residues to cysteine and 
assaying for disulfide cross-linking between p10 and CA.  
Initial experiments conducted with air oxidation showed promise, but 
cross-linking was inefficient, possibly due to residual dithiothreitol (DTT) from 
the protein purification procedure. To improve cross-linking, I developed a 
chemical oxidation protocol using copper phenanthroline as the oxidizing 
agent, p-chloromercuribenzoic acid (PCMB) or iodoacetamide as a 
“quenching” reagent to decrease non-specific cross-linking of oxidized 
cysteines, and neocuproine as a scavenger to inactivate the excess copper. 
(PCMB caused a noticeable band shift in some assays and was eventually 
replaced with iodoacetamide.) This protocol dramatically improved cross-
linking efficiency but led to extensive non-specific cross-linking of the 12 
endogenous cysteines in the ΔMBDΔPR protein (data not shown). In order to 
reduce this interference, I mutated the cysteines in MA, p2, and NC to alanine 
or serine (Figure 3.4a). One endogenous cysteine, C192 in the C-terminal 
domain of CA, was known from previous studies to disrupt assembly when 
mutated to serine (77) and was therefore left in place. The resulting construct, 
ΔMBD(-11C) [hereafter called -11C] assembled in vitro into normal spherical 
particles (Figure 3.4b). All subsequent cysteine mutations were made in the 
context of -11C. Mutation of p10 E51 [E51C], CA T20 [T20C], or both [CC] to 
cysteines allowed spherical assembly in vitro (Figure 3.4b), although the  
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Figure 3.3: Extended NTD structure predicts disulfide cross-linking when 
E51 of p10 and T20 of CA are mutated to cysteines(A) High-resolution 
structure of the extended NTD dimer (1P7N) showing disulfide bonds 
predicted to form when p10 E51 and CA T20 are mutated to cysteines. 
The disulfide bonds (yellow) link CA (orange) and p10 (purple) domains 
across the dimer interface. Those residues that form the β-hairpin in 
mature CA are shown in red. (B) Close-up of boxed area in A showing the 
predicted E51C-T20C disulfide bond.
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Figure 3.4: Cysteine mutant constructs used for cross-linking. (A) 
Schematic representation of ΔMBDΔPR showing locations of the 
endogenous cysteine residues and the cysteine mutations used in this 
study. (B) Transmission electron microscopy images of ΔMBDΔPR 
cysteine mutants assembled in vitro and negative stained. -11C, top left; 
E51C, top middle; T20C, top right; CC, bottom left; TWCC, bottom middle; 
P38CC, bottom right. Scale bars represent 500 nm. 
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E51C single mutant assembled less efficiently. Both -11C and E51C were 
found to assemble more efficiently at pH 6.0 than at pH 6.5, and some 
assemblies of these proteins were performed at the lower pH. As a negative 
control for assembly, the p10 T43A and W45A mutations, which abrogate 
assembly (Table 3.1), were combined with the CC construct to produce 
TWCC (Figure 3.4a); as predicted, TWCC did not assemble (Figure 3.4b), 
confirming that the cysteine mutations could not rescue a p10-CA interface 
defect. 
In initial experiments, I performed cross-linking on unassembled protein 
(protein under assembly conditions with no nucleic acid added) and on total 
assembly reactions (DNA oligonucleotide GT50 added at 10% wt/wt). Samples 
were incubated with and without RSV PR to separate the Gag domains and 
thus identify the site(s) of cross-linking. Digested samples were then analyzed 
by non-reducing SDS-PAGE. Potential outcomes of these cross-linking 
experiments are diagrammed for reference in Figure 3.5. 
Upon analysis, -11C protein produced bands consistent with 
monomeric full-length (50 kDa) and CA (27 kDa) proteins under all conditions 
(Figure 3.6a, lanes 1-3), suggesting that C192 in CA does not form disulfide 
bonds under these experimental conditions. E51C protein produced three 
bands in the absence of PR (Figure 3.6a, lane 4): a monomer, an upshifted 
monomer (due to PCMB modification of p10; data not shown), and a dimer. As 
the E51C CA was monomeric (Figure 3.6a, lanes 5-6), the dimer was 
presumably due to p10-p10 cross-linking (see Figure 3.5, example 1). Full-
length T20C protein and T20C CA were also predominantly monomeric 
(Figure 3.6a, lanes 7-9), suggesting that C20 alone does not form either 
homotypic or heterotypic (with C192) disulfide bonds. Full-length CC protein 
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Figure 3.5: Possible outcomes of disulfide cross-linking of cysteines in 
p10 and CA when analyzed by non-reducing SDS-PAGE after PR 
cleavage. Heavy black lines represent disulfide bonds. 
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Figure 3.6: p10-CA cross-linking is seen upon introduction of cysteines 
predicted to form disulfide bonds across the p10-CA interface. A. 
Constructs with wild-type PR cleavage sites. Addition of nucleic acid to 
reaction and PR to digests is noted above each lane. Samples on the far 
right are reduced. Note novel 37 kDa band in lanes 11-12. B. Constructs 
with p10-CA cleavage site knocked out. Note p10-CA dimers in lanes 5-6 
and 11-12 and high MW band in lane 12. 
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produced both monomer and dimer bands (Figure 3.6a, lane 10), while PR 
digestion yielded three distinct CA bands (Figure 3.6a, lanes 11-12): a 
monomer, a 37 kDa band (boxed) as predicted for p10-CA cross-linking 
(Figure 3.5, example 2), and a very faint, approximately 50 kDa band. The 50 
kDa band might represent a CA dimer (Figure 3.5, example 3), although this 
seems unlikely as no comparable band was produced by digested T20C 
protein. More likely, the 50 kDa band results from incomplete PR digestion of 
the cross-linked product. (In this and subsequent experiments, cross-linked 
CC protein was difficult to digest completely under non-reducing conditions.) 
The pattern for PR digested CC protein was the same whether or not nucleic 
acid was added, suggesting that the cross-linking seen did not depend on the 
presence of assembled particles.  
To confirm that higher species were due to disulfide bond formation, I 
also digested assembled samples under reducing conditions and analyzed 
them by standard reducing SDS-PAGE. All samples reduced to monomeric 
CA products (Figure 3.6a, lanes 13-16), indicating that higher species were 
due to disulfide cross-linking. Immunoblotting using constructs with an 
internally HA-tagged p10 confirmed that the 37 kDa band observed for 
digested CC protein contains both p10 and CA (Figure 3.7). These results 
confirm disulfide bonding between the exogenous cysteine residues C51 of 
p10 and C20 of CA. 
To distinguish between intra- and inter-molecular cross-linking, I 
compared PR-digested samples from constructs with wild-type cleavage sites 
to samples from parallel constructs in which the p10-CA cleavage site was 
abolished by combining the cysteine mutations with the p10(58-62)f mutation 
(p10(58-62)f) allows assembly (Table 3.1) but disrupts PR cleavage). The 
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Figure 3.7: Novel 37 kDa band contains p10 and CA. -11C and CC 
constructs were made with an internal HA tag in p10. Unassembled 
proteins were oxidized and quenched as described and analyzed by 
immunoblotting with antibodies to CA and HA. Note that 37 kDa band is 
recognized by both antibodies. 
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combination yielded constructs -11Cf, E51Cf, fT20C, and CfC. When analyzed 
by non-reducing SDS-PAGE as before, intermolecular p10-CA cross-linking of 
the CfC construct should yield a 37 kDa band when the cleavage site is intact 
(Figure 3.5, example 2) but a 74 kDa band when cleavage is disrupted 
(Figure 3.5, example 5), whereas intramolecular cross-linking should yield a 
37 kDa band in either case (Figure 3.5, examples 2 and 6).  
The -11Cf, E51Cf, and fT20C constructs produced monomeric full-
length and 37kDa p10-CA bands as predicted (Figure 3.6b, lanes 1-9). E51Cf 
also produced an upshifted full-length band (Figure 3.6b, lane 4) due to 
PCMB modification (data not shown) and dimeric p10-CA bands (Figure 3.6b, 
lanes 5-6), due presumably to p10-p10 cross-linking (Figure 3.5, example 4). 
In addition to the bands seen for E51C, CfC produced a third, very high 
molecular weight species, but only when nucleic acid was added (Figure 3.6b, 
lane 12). All high molecular weight species, including the very large species 
produced by CfC, disappeared under reducing conditions, confirming that the 
high molecular weight species were produced by disulfide cross-linking. 
Based on these results, I initially hypothesized that the dimeric 
intermolecular p10-CA interface seen in the extended NTD structure did not 
exist in virus-like particles but represented an intramolecular (monomeric) p10-
CA interface found in both unassembled Gag and in the virus particle. I 
attributed the p10-p10 dimers to transient interactions between unassembled 
proteins and the very high molecular weight species produced by assembled, 
digested CfC to non-VLP aggregates formed during assembly. 
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Cross-linked Gag in particles is multimeric 
To test my initial hypothesis that the p10-CA interface is intramolecular 
in virus-like particles, I subjected cross-linked, non-digested CfC assembly 
reactions to equilibrium sedimentation analysis on 10-60% sucrose gradients. 
Under these conditions, particles are expected to migrate to approximately 
fraction 12 (45% sucrose, density = 1.22), while unassembled proteins remain 
at the top of the gradient and aggregates migrate to the bottom of the gradient. 
Surprisingly, the fractions that contained VLPs contained predominantly high-
molecular weight cross-linked species (Figure 3.8, boxed bands and TEM 
inset). This suggested that the p10-CA interface in virus-like particles is 
intermolecular rather than intramolecular and that the species trapped by 
cross-linking p10 and CA in VLPs is much larger than a dimer. 
 
p10-CA cross-linking is intramolecular and non-specific in solution 
Disulfide cross-linking of Gag proteins can occur in situations other than 
stable contacts between folded proteins in virus-like particles, including 
transient interactions between proteins in solution, protein-protein interactions 
in misassembled aggregates, and interactions between denatured proteins in 
SDS-PAGE preparations. The probability of such non-specific cross-linking 
can be decreased by quenching any remaining cysteines with an excess of a 
sulfhydryl-reactive reagent prior to denaturation with SDS and by purifying 
VLPs prior to cross-linking, but these tactics are not 100% effective. To 
distinguish between interface-specific and non-specific p10-CA cross-linking, I 
made an additional construct by mutating p10 P38 at the beginning of the 
critical region (Figure 3.2) to cysteine and combining it with T20C to make 
P38CC (Figure 3.4a). P38 was chosen because it allows assembly when  
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Figure 3.8: Gag in virus-like particles is multimeric. Total assembly reaction 
using CfC construct was analyzed by equilibrium sedimentation on 10-60% 
sucrose gradient. VLPs were visible in the gradient and were found in 
fractions 12-13 (TEM inset). Fractions were digested with PR and 
subjected to SDS-PAGE. Note that cross-linked protein in lanes 12-13 is 
predominantly multimeric. 
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mutated to alanine (Table 3.1) but is over 15Å away from T20 of the other 
subunit in the extended NTD structure, making disulfide formation between 
cysteines at these sites impossible in the context of the p10-CA interface 
depicted in the crystal structure. P38CC should thus allow non-specific p10-
CA cross-linking (during transient collisions or when proteins are denatured) 
but should not support cross-linking if the p10-CA interface depicted in the 
extended NTD structure is present. The P38CC protein assembled as 
expected (Figure 3.2b) and was used in the following experiments as a 
specificity control for the presence of the p10-CA interface. 
I first examined the specificity of p10-CA cross-linking in unassembled 
proteins by oxidizing under assembly conditions without nucleic acid. As 
before, I incubated samples with and without RSV PR to localize cross-linking 
and analyzed the products by non-reducing and reducing SDS-PAGE. The 
results are shown in Figure 3.9. In the absence of PR or reducing agent, all 
constructs were predominantly monomeric with the exception of E51C (Figure 
3.9, top left, lane 2), which was largely dimeric. The dimers are due to p10-p10 
disulfide cross-linking, as the CA band is monomeric upon digestion (Figure 
3.9, bottom left, lane 2) and the full-length dimer disappears upon reduction 
(Figure 3.9, top right, lane 2). All three constructs with exogenous cysteines in 
both p10 and CA show a 37 kDa band upon PR digestion (Figure 3.9, bottom 
left, lanes 4-6). As the full-length proteins are monomeric (Figure 3.9, top left, 
lanes 4-6) and the digested bands reduce to 27 kDa (Figure 3.9, bottom right, 
lanes 4-6), the 37 kDa band is most likely due to intramolecular p10-CA 
disulfide cross-linking (Figure 3.5, example 6). As the CC construct appears 
identical to both controls (TWCC, which is not predicted to form the p10-CA 
interface, and P38CC, which is not predicted to cross-link across the  
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Figure 3.9: Unassembled proteins cross-link non-specifically. Samples 
were oxidized, quenched, and treated as described in the text, before 
SDS-PAGE. Lane 1, -11C; lane 2, E51C; lane 3, T20C; lane 4, CC; lane 
5, P38CC. In the bottom panel the samples were treated with PR before 
SDS-PAGE. Samples on left were not reduced. Samples on the right were 
reduced before PR digestion and SDS-PAGE. The 37 kDa band appears 
in lanes 4, 5, and 6 on the lower left. 
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interface), I concluded that unassembled protein forms intramolecular p10-CA 
disulfide bonds in a non-specific manner. This experiment also validated the 
specificity control P38CC: the P38CC protein demonstrates non-specific p10-
CA cross-linking in the absence of the p10-CA interface depicted in the 
extended NTD structure. 
 
p10-CA cross-linking is intermolecular and specific in in vitro assembled 
virus-like particles 
To test for the presence of the p10-CA interface in assembled particles, 
I purified virus-like particles from assembly-competent constructs (therefore 
excluding TWCC) by equilibrium sedimentation, oxidized the particles (with or 
without stoichiometric amounts of DTT), and quenched as described in 
Chapter 2. I incubated the oxidized particle samples with and without 
recombinant RSV PR to separate the Gag domains and analyzed the products 
by non-reducing and reducing SDS-PAGE. The results are shown in Figure 
3.10. The -11C protein was predominantly monomeric for both full-length 
protein (Figure 3.10, top left, lane 1) and CA (Figure 3.10, bottom left, lane 1), 
and neither band shifted upon reduction (Figure 3.10, top and bottom right, 
lane 1), indicating that C192 in the CTD does not form homotypic disulfide 
bonds under these assay conditions. Some of the full-length E51C protein 
(Figure 3.10, top left, lane 2) was dimeric under non-reducing conditions but 
reduced to a monomer (Figure 3.10, top right, lane 2), while the CA was 
monomeric even when oxidized (Figure 3.10, bottom left, lane 2), suggesting 
that the full-length dimers were due to p10-p10 disulfide bonds (Figure 3.5, 
example 1). Notably, there was no evidence that C51 in p10 was able to 
cross-link to C192 in CA. Full-length T20C protein (Figure 3.10, top left, lane  
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Figure 3.10: Exogenous cysteines in p10 and CA form specific, 
intermolecular disulfide bonds in virus-like particles. Particles were 
oxidized, quenched, and treated as described in the text, before SDS-
PAGE. Lane 1, -11C; lane 2, E51C; lane 3, T20C; lane 4, CC; lane 5, 
P38CC. In the bottom panel the samples were treated with PR before 
SDS-PAGE. Samples on left were not reduced. Samples on the right 
were reduced before PR digestion and SDS-PAGE. The novel high 
molecular weight band appears in lane 4 on top left, and the novel shifted 
CA band appears in lane 4 on bottom left. 
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3) also formed disulfide-mediated dimers, although to a lesser extent. These 
must be CA-CA dimers as there are no cysteine residues in any other Gag 
domain, and upon PR digestion a faint corresponding upper band is present at 
approximately 50 kDa (Figure 3.10, bottom left, lane 3) as predicted for a CA 
dimer (Figure 3.5, example 3). It is not possible to distinguish whether these 
dimers are mediated by C20-C20 or C20-C192 disulfide bonds, and both 
species may well be present; in any case, the majority of the T20C protein is 
monomeric. The results for these single mutants suggest that neither of the 
exogenous cysteines, C51 in p10 or C20 in CA, produces extensive cross-
linking when introduced alone.  
In contrast to the preceding control proteins, full-length CC protein 
(Figure 3.10, top left, lane 4) formed a distinct, very high MW band with 
almost no monomer or dimer present, while the CA band (Figure 3.10, bottom 
left, lane 4) was shifted upward by approximately 10 kDa with no 27 kDa CA 
remaining. Both full-length and CA bands reduced to the normal monomer 
position (Figure 3.10, top and bottom right, lane 4), confirming that the band 
shifts observed were due to disulfide bonds. For the specificity control P38CC, 
the full length protein was largely dimeric (Figure 3.10, top left, lane 5), but the 
CA was predominantly monomeric with a very faint upper band similar to that 
seen for T20C (Figure 3.10, bottom left, lane 5). This suggests that most of 
the full-length dimers were due to p10-p10 disulfide bonds mediated by C38 
(Figure 3.5, example 1), with a few CA-CA disulfides as for T20C (Figure 3.5, 
example 3); again, there was no evidence of p10-CA cross-linking, indicating 
that C38 in p10 was unable to form disulfide bonds with either C20 or C192 in 
CA. This was in marked contrast to the results seen for oxidized unassembled 
protein, in which either C38 or C51 in p10 was able to cross-link to C20 in CA 
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(Figure 3.9), and suggests that the measures taken to purify VLPs prior to 
oxidation and to quench remaining cysteines prior to denaturation were largely 
successful in eliminating non-specific p10-CA cross-linking. Together, the 
cross-linking results indicate that the p10-CA interface depicted in the 
extended NTD crystal structure is present in virus-like particles but that the 
cross-linked species is much larger than the predicted dimer. 
  
p10-CA cross-linking is intermolecular and specific in cell-produced 
virus-like particles 
To ensure that these results did not represent an artifact of in vitro 
assembly or of chemical oxidation, I made parallel versions of the constructs 
described above in an MLV-based retroviral vector expressing RSV Gag with 
the PR domain removed. Because the RSV nuclear export signal is contained 
within the region of p10 under study and includes the W45 residue, it seemed 
likely that the TWCC construct, and possibly others as well, would be trapped 
in the nucleus and would therefore be unable to assemble and bud. To avoid 
this problem, all cell expression constructs included a modified MA domain 
called Super M which contains two mutations in the membrane-binding 
domain of MA, E25K and E70K. The net +4 charge is reported to increase the 
affinity of Gag for the plasma membrane and thereby to bypass nuclear transit 
(14); combining Super M MA with the constructs described in Figure 3.4a was 
predicted to ensure that all Gag proteins reached the plasma membrane. 
I created DF1 (chicken embryonic fibroblast) cell lines stably expressing 
these constructs by MLV transduction. Virus-like particles produced by the cell 
lines were collected and quenched as described in Chapter Two, 
permeabilized with mild detergent treatment to disrupt the viral envelopes, 
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incubated with and without PR, and analyzed by reducing and non-reducing 
SDS-PAGE and immunoblotting. All proteins were expressed (data not shown) 
and all constructs except for TWCC were able to assemble and bud from cells 
(Figure 3.11). Gag was monomeric or dimeric and CA was the correct size in 
particles produced from all constructs except for CC(-11C), which produced a  
high molecular weight Gag complex and an upward-shifted CA, exactly as 
seen in vitro (Figure 3.11, top left, lane 4). I concluded that the interaction 
between p10 and CA occurs in membrane-enclosed VLPs produced from cells 
as well as in particles assembled with purified protein in vitro, and that efficient 
disulfide bond formation can occur by air oxidation. 
  
The p10 and CA domains of Gag become cross-linked as a hexamer 
To identify the high MW band produced by undigested CC, the high 
molecular weight product was isolated and partly reduced to form a ladder. 
Due to the amount of protein required, the parallel construct with the mutated 
p10-CA cleavage site, CfC(-11C), was used. As described above, this protein 
combines the CC construct with the p10(58-62)GSGSG mutation, which 
allows assembly but destroys the p10-CA cleavage site. In the absence of PR, 
CfC behaves similarly to CC, but it can consistently be purified with a much 
higher yield. I assembled, collected and oxidized VLPs as previously 
described and then resuspended the particles in 500 mM NaCl plus 2M urea 
to disrupt weak non-covalent intermolecular interactions. The resulting sample 
was subjected to rate-zonal centrifugation in a sucrose gradient to separate 
protein complexes by size, and the fractions were analyzed by non-reducing 
SDS-PAGE (Figure 3.12). Two distinct protein complexes were observed: a 
major complex that migrated significantly more slowly than 212 kDa and a  
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Figure 3.11: Specific intermolecular p10-CA cross-linking occurs on air-
oxidation of virus-like particles produced from cultured avian cells. 
Particles were quenched and treated as described in the text before SDS-
PAGE and immunoblotting with rabbit anti-CA serum. Lane 1, -11C; lane 
2, E51C; lane 3, T20C; lane 4, CC; lane 5, TWCC; lane 6, P38CC. 
Samples in the bottom panels were treated with PR before SDS-PAGE. 
Samples on left were not reduced. Samples on the right were reduced 
before PR digestion and SDS-PAGE. The novel high molecular weight 
band appears in lane 4 on top left, and the novel shifted CA band appears 
in lane 4 on bottom left. 
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Figure 3.12: High MW Gag complex contains two species. Analysis by 
rate-zonal centrifugation.  Cross-linked particles were dissolved in 2M 
urea and 0.5M NaCl, mixed with E. coli β-galactosidase as an internal 
size standard, and then centrifuged on a sucrose gradient with the same 
solutes. The gradient was divided into 17 fractions and portions were 
subjected to SDS-PAGE. 
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larger minor complex that may represent a dimer of the major complex (i.e. a 
ΔMBDΔPR dodecamer made by two incompletely cross-linked hexamers that 
became cross-linked to one another). I estimated the sedimentation coefficient 
of the major complex at 10S relative to tetrameric β-galactosidase (a 440 kDa 
tetramer), which would correspond approximately to a globular protein of 300 
kDa. (ΔMBDΔPR is a 52 kDa protein.) 
Gradient fractions that contained only the major complex, such as lane 
9 from Figure 3.12, were pooled, concentrated, and subjected to β-
mercaptoethanol at a range of concentrations to empirically determine the best 
concentration to produce a ladder when subjected to non-reducing SDS-PAGE 
(Figure 3.13). Once the optimal concentration of 0.25% β-mercaptoethanol 
was determined, the partially reduced complex was subjected to non-reducing 
SDS-PAGE on a 3-8% gradient Tris-acetate gel. These conditions yielded a 
ladder of six bands spaced at approximately 50 kDa intervals (Figure 3.14), of 
which the highest band is the same size as the non-reduced complex and the 
lowest is the correct molecular weight for a ΔMBDΔPR monomer (~52 kDa). I 
concluded that the major protein complex is a hexamer linked by p10-NTD 
disulfide bonds. 
  
Implications of the p10-CA interface for immature vs. mature NTD 
hexamer structure 
The results above implied that the extended NTD structure is a dimeric 
version of the six-fold p10-CA hexamer observed in particles. This idea 
presented two difficulties. The first was that comparison of the amino acids 
involved in the RSV p10-CA interface with those involved in the only available 
hexameric NTD-NTD interface, that of MLV (87, 88), revealed a conflict: many  
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Figure 3.13: Optimal reducing agent concentration for partial reduction of 
the high MW complex was determined empirically. Gradient fractions 
containing purified “major” high MW complex, such as Figure 3.12 lane 9, 
were pooled, concentrated, mixed with indicated amounts of β-
mercaptoethanol (βME) and analyzed by SDS-PAGE. Samples were boiled 
with SDS and the βME was added immediately before loading. Top: 
“Coarse” determination analyzed on 10% acrylamide gel. Bottom: “fine” 
determination analyzed on 7% acrylamide gel. 
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Figure 3.14: Major species in high MW Gag complex is a hexamer. 
Samples containing the major high MW band, such as lanes 9 and 10 in 
Figure 3.12, were pooled, concentrated, and partially reduced with β-
mercaptoethanol. SDS-PAGE was performed on NuPAGE Tris-Acetate 3-
8% gradient gels (Invitrogen). 
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structurally homologous residues are involved in both structures (Figure 3.15), 
implying that the extended NTD p10-CA interface and the hexameric CA-CA 
interface cannot exist simultaneously. This suggests that if a p10-CA interface 
exists in the immature NTD hexamer then the immature NTD hexamer must 
be significantly different from the mature NTD hexamer in order to 
accommodate p10. The second problem was that the unfolded β-hairpin 
region must bend to allow a next-neighbor p10-CA contact in the NTD 
hexamer. This is diagrammatically represented in Figure 3.16. The 25 
residues of p10 are drawn as a hook that acts like a flap contacting a 
neighboring NTD. In the dimer the shaft of the hook is straight and the NTDs 
are symmetrically arranged, pointing in opposite directions, an orientation that 
is inferred to be biologically irrelevant. In the hexamer, the shaft of the hook 
must be bent to accommodate the same p10-NTD side chain contacts as in 
the dimer. To resolve these conundrums, I entered into collaboration with Paul 
S. Murray and Diana Murray, who have experience with molecular modeling, 
in order to model mature and immature RSV NTD hexamers. 
The models generated by the Murray group are shown in Figure 3.17. 
In this panel the top three of the six subunits are drawn in space-filling style, 
with the protein-protein interactions shown by arrows between CA helices 
(numbers) or between the p10 segment (p) and CA helices. The bottom three 
subunits are drawn to show the polypeptide itself in ribbon style. The mature 
hexamer is based on the MLV CA NTD hexamer as determined by 
crystallography, which is stabilized primarily by interactions between the N-
terminal β-hairpins of adjacent subunits and between the first helix of adjacent 
subunits, and secondarily by interactions between helix 2 and helix 3 of 
adjacent subunits (88). It should be noted that differences between the RSV  
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 Figure 3.15: p10-CA interface from extended NTD structure overlaps 
with CA-CA interface in MLV NTD hexamer. A. Extended NTD monomer 
colored by helix. B. Annotated amino acid sequence of the RSV 
extended NTD, including 25 amino acids of p10. Asterisks above the 
sequence indicate residues involved in the extended NTD dimer interface 
(91). Plus signs below the sequence indicate the amino acids most 
structurally homologous to the MLV residues involved in the MLV mature 
NTD hexamer interface (88). Secondary structural elements are indicated 
with colors corresponding to panel A above; note that while the helices 
are valid for both structures, the β-hairpin (red) is present only in mature 
CA. 
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Figure 3.16: Schematic representation of p10-CA interaction in the 
extended NTD. Left: crystallographic dimer. Right: the hexamer proposed 
to form in immature particles. p10 is represented by the purple line, β-
hairpin residues by the red line, and the remainder of the NTD by solid 
shapes. Small yellow circles represent the N-terminus of the extended 
NTD. 
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 Figure 3.17: Molecular models of mature and immature RSV CA NTD 
hexamers with approximate helix positions and interactions indicated. 
Top: Molecular model of mature RSV NTD hexamer based on mature 
MLV NTD structure. The upper three subunits of the hexamer are shown 
as solid space-filled surfaces while the lower three subunits are shown 
as transparent surfaces superimposed on ribbon diagrams. On the 
ribbon diagrams the N-terminus is space-filled in yellow and the C-
terminus in green. The β-hairpin ribbon is in dark red. Approximate helix 
positions are indicated by labeled circles. Dark arrows indicate direct 
intermolecular CA-CA interactions predicted from the MLV NTD hexamer 
and tan arrows indicate predicted water-mediated interactions. Bottom: 
Molecular model of immature RSV NTD hexamer based on extended 
NTD structure and mature MLV NTD hexamer. On the ribbon diagrams 
p10 residues are dark purple and the unfolded β-hairpin residues dark 
red; the depiction is otherwise similar to the mature model. White arrows 
indicate intermolecular p10-CA interactions and black arrows indicate 
possible intramolecular interactions.
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and MLV monomer structures mean that the relative helix positions within the 
hexamer are somewhat different as well, and thus the interactions inferred 
from the MLV structure must be considered approximate for RSV. 
 The addition of p10 in the immature model expands the hexamer 
(Figure 3.17, bottom), opening up a much larger hole in the center. While the 
nature of the model does not allow for exact measurements, the immature 
hole is approximately three to four times larger than the mature hole (88), 
approximately 42 Å compared to approximately 12 Å for the mature hexamer. 
A similarly large hole in the NTD hexamer of the immature HIV-1 Gag lattice 
was recently observed in immature HIV-1 particles analyzed by electron cryo-
tomography (130). I provided a sample of in vitro assembled RSV VLPs for 
analysis by the same technique, and the RSV particles also have large central 
cavities in the NTD hexamers (John Briggs, personal communication). The 
cryotomography results are consistent with the Murray model for the immature 
RSV NTD hexamer, providing another line of evidence that the p10-CA 
interface depicted in the extended NTD structure is present in the immature 
NTD hexamer. 
 
DISCUSSION 
 
 Retroviral assembly is a multi-step process in which the structural 
protein Gag assembles into immature particles, and then is cleaved by the 
viral protease PR into products that re-assemble to form the internal structure 
of the mature infectious virus. The CA domain of Gag forms a hexameric 
lattice in both immature and mature particles, but differences in the lattice 
suggest that the Gag-embedded CA and the liberated CA make different 
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protein-protein contacts. The nature of these differences is not well 
understood. The N-terminal β-hairpin of free CA is highly conserved and is 
important for correct mature assembly of at least some (123) retroviruses. In 
addition, Rous Sarcoma virus has a specific sequence requirement for correct 
immature assembly, namely the C-terminal 25 amino acids of the p10 domain 
that adjoin CA (58). A high-resolution structure of an RSV NTD extended to 
include this critical region of p10 showed a dimer with an extensive p10-NTD 
interface (91), but the relevance of this structure to immature assembly was 
uncertain prior to the work presented in this thesis. 
I have now provided evidence that the p10-NTD interface identified in 
the structure is relevant to immature assembly, but that in immature virus 
particles the interface forms a hexamer rather than a dimer. Since the NTD is 
believed to form a hexamer in both the immature and the mature CA lattices, I 
concluded that p10 participates in the immature NTD hexamer. This is the first 
example of a critical heterologous interdomain Gag-Gag contact in retroviral 
assembly.  
The interaction between p10 and the NTD in the extended NTD 
structure is incompatible with the NTD-NTD interactions seen in the MLV 
mature NTD hexamer structure (88). Molecular modeling of an immature RSV 
NTD hexamer, based on the RSV extended NTD dimer and the MLV hexamer 
structures, shows that the p10-NTD interaction forces the NTD subunits further 
apart, opening a central cavity. The final NTD arrangement is strikingly similar 
to that seen for immature HIV-1 particles (130) and RSV particles (John 
Briggs, personal communication) examined by electron cryotomography. This 
similarity suggests that immature retroviral lattices are structurally 
homologous, just as are their mature CA proteins. However, it is unknown by 
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what mechanism the HIV-1 NTD lattice is expanded in the immature lattice as 
compared with the mature lattice.  
In vitro studies of HIV-1 assembly show that assembly pH acts as a 
morphological switch for immature-like assembly: an HIV-1 Gag protein 
lacking the C-terminal p6 domain and amino acids 16-99 of MA assembles 
only into spheres at pH 8.0 but assembles into both spheres and tubes at pH 
6.5 (50). The assembly morphology switch is paralleled by changes in epitope 
availability in the NTD of monomeric Gag, with epitopes in helix 3 and helix 6 
available at pH 8.0 but masked at pH 6.5 (50). These results suggest that for 
HIV-1 a pH-mediated conformational change in Gag – which may reprise 
changes caused by PR cleavage in vivo – is responsible for the switch 
between immature-like spheres and mature-like tubes. The molecular nature 
of this switch remains to be unraveled. 
Electron cryotomography has recently provided the first data on the 
retroviral immature lattice (130). This study shows that in contrast to the 
mature lattice, the immature lattice has the NTD hexamers more widely 
spaced, with almost no NTD-NTD contact within the hexamer, and the CTDs 
more tightly packed. The hexamer appears to be stabilized by interactions 
among the spacer domains C-terminal to the CTD, a region that is also 
important for RSV assembly (60) In addition, a novel “domain-swapped” 
structure has been proposed for the HIV-1 CTD (54); this dimer is much tighter 
than the traditional dimer structure seen for both purified protein (42) and the 
reconstructed mature lattice (43), and it is tempting to speculate that the 
immature lattice, with its greater stability and tighter CTD spacing, 
incorporates the domain-swapped CTD dimer instead. 
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The model of the RSV immature NTD hexamer presented above is 
similar to the NTD hexamers observed by cryotomography, with widely spaced 
monomers and a large central cavity. However, in contrast to the immature 
HIV-1 lattice, in which neither the NTD nor MA appears to stabilize the 
hexamer (130), the RSV immature hexamer is stabilized, at least in part, by 
p10-NTD interactions. This difference is not surprising: previous studies with 
chimeric RSV-HIV-1 Gag constructs have shown that constructs with RSV CA 
require the critical p10 sequence from RSV upstream for assembly, while 
constructs with HIV-1 CA tolerate RSV sequence upstream (2), suggesting 
that the HIV-1 CA domain does not interact with upstream Gag sequences. 
Similar studies with chimeric MLV and spleen necrosis virus (SNV) Gag 
constructs show that assembly of these distantly related gammaretroviruses 
also requires that the domain upstream of CA (p12) be homologous to the CA 
domain. I therefore speculate that the gammaretrovirus immature hexamer 
may be stabilized by interactions between CA and p12. 
The incompatibility of the immature p10-CA interaction with the mature 
MLV hexamer supports the idea that retroviruses have distinct immature and 
mature NTD-NTD interfaces, with PR cleavage favoring the mature over the 
immature interface. The participation of the upstream p10 domain in the 
immature lattice is intriguing because it suggests a mechanism by which 
proteolysis leads to maturation. The RSV p10 domain both stabilizes the 
immature hexamer and prevents mature NTD-NTD contacts from forming. The 
maturation process can thus be imagined as follows: upon PR activation, 
cleavage between p10 and CA destabilizes the immature hexamer and allows 
p10 to diffuse away from CA, which in turn unmasks mature contact surfaces 
and allows the mature NTD hexamer to form (Figure 3.18). 
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Figure 3.18: RSV CA NTD hexamer maturation model. PR cleavage 
between p10 and CA allows the immature hexamer to dissociate. The p10 
domain diffuses away, allowing the β-hairpin to fold. The mature NTD then 
reassembles into the mature hexamer.
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 The nature of the link that couples proteolysis to maturation is likely to 
differ among retroviral families. There are three broad categories of 
mechanisms by which PR cleavage can change the CA-CA contacts: by 
initiating refolding of CA, by removing sequences that promote immature 
contacts, or by removing sequences that inhibit mature contacts. The first 
mechanism, exemplified by the refolding of the β-hairpin, is well documented.  
Disrupting the β-hairpin of Mason-Pfizer monkey virus (MPMV) CANC 
by removing the N-terminal proline converts the in vitro assembly products 
from disorganized aggregates into spherical particles (120), suggesting that 
proteolytic refolding is incompatible with the immature lattice. HIV-1 appears to 
use both refolding (based on pH-dependent epitope availability) and removing 
required sequences; since the immature hexamer is stabilized by interactions 
between downstream SP1 domains, proteolysis should dissociate the 
immature hexamer. For RSV, the contact between p10 and CA both stabilizes 
the putative immature NTD hexamer and interferes with the inferred mature 
NTD-NTD contacts, so PR cleavage between p10 and CA both destabilizes 
the immature particle and promotes mature assembly. Thus, while the 
structural properties of both immature and mature retroviral particles appear to 
be similar across families, the mechanics of maturation may prove to be quite 
different. 
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CHAPTER FOUR 
ASSEMBLY OF ROUS SARCOMA VIRUS GAG BY ARTIFICIAL 
DIMERIZATION 
 
INTRODUCTION 
 
Dimerization appears to be a critical initial step in retroviral assembly. 
HIV-1 Gag has been demonstrated to bud from cells when the NC domain of 
is replaced by a dimeric “leucine zipper” (1, 137). The same result is seen for 
RSV in a baculovirus/Sf9 expression system, with normal particle morphology 
confirmed by electron microscopy (56); this result had not, at the inception of 
this thesis research, been confirmed in native (chicken) cells. Dimerization 
seems sufficient to induce assembly in vitro as well: while diverse nucleic 
acids support assembly, there is a minimum oligonucleotide size that for RSV 
corresponds to two NC-binding sites (79). In addition, both dimerizing and 
trimerizing leucine zippers have been used to drive HIV-1 assembly in vitro 
(Alan Rein, personal communication). Replacement of HIV-1 NC with a single 
cysteine residue that is oxidized to form disulfide-mediated dimers also leads 
to assembly in vitro (4). In the case of RSV, for which the CTD of CA does not 
dimerize in solution as it does for HIV-1, C-terminal Gag dimerization has been 
hypothesized to cause a conformational change in the CTD of CA, activating 
the CTD for Gag multimerization and assembly (78). While a mathematical 
argument suggests that dimerization will increase the probability of assembly 
even in the absence of any such activation step (140), ample evidence 
indicates that dimerization plays a specific role in retroviral assembly. 
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No artificial dimerization system has proven successful for RSV 
assembly in vitro. Attempts by a former student in this laboratory to replace the 
NC domain with a leucine zipper in the RSV in vitro system yielded a poorly 
soluble protein that failed to assemble in vitro; thin section TEM of E. coli 
expressing this construct showed only low numbers of excessively small (25-
30 nm) particles (77). One hypothesis to explain this failure is that in this 
construct, a functional element that spans the SP-NC cleavage site was 
interrupted when NC was replaced by a dimerization domain (Figure 4.1). 
This phenomenon was first seen when RSV NC was replaced with a leucine 
zipper in the baculovirus expression system. While the simple fusion produced 
correct spherical particles, inclusion of a five amino acid spacer between SP 
and the zipper produced cylindrical particles (56) (Figure 4.2). Further 
mapping of the element showed that it spans the C-terminal tail of CA, the SP 
domain, and the first four amino acids of NC (60) (Figure 4.1). Disruption of 
this sequence by insertion or substitution produced cylindrical Gag particles in 
insect or chicken cells (60); constructs parallel to those that make cylindrical 
particles in cells failed to assemble in vitro (59). The role of this element in 
RSV assembly is not fully characterized, although it likely relates to the 
internal pillar-like structures seen in cryo-tomograms of HIV-1 (130) and RSV 
(John Briggs, personal communication) immature particles and described in 
Chapter One of this thesis (Figure 1.10, magenta structures). 
The previous leucine zipper chimera involved fusing the zipper domain 
directly to the C-terminus of SP (Figure 4.1), thus removing the last four 
amino acids of the CA-SP-NC element. While such a fusion formed spherical 
particles in the baculovirus expression system, it is possible that the degree of 
overexpression inherent to that system masks some subtle defect in  
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Figure 4.1: Novel morphology-determining element in RSV Gag spans 
the CA-SP-NC cleavage sites. CA-SP-NC element is indicated by heavy 
black line. PR cleavage sites are indicated by vertical lines. Sites of Gag-
dimerization domain fusions are indicated by arrows. Figure adapted from 
reference (60). 
SP/NC 
fusion site 
NC +4 
fusion site
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Figure 4.2: Replacement of RSV NC with leucine zipper domain in the 
baculovirus expression system yields morphologically normal particles, but 
inclusion of a five amino acid linker (GSGSG) between SP and the zipper 
yields cylindrical particles. Figure taken from reference (56). 
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assembly. Inclusion of the entire CA-SP-NC element may allow for an efficient 
in vitro leucine zipper-mediated assembly system for RSV. 
 Artificial dimerization-assembly systems are of interest in part because 
of the additional features that they contribute to assembly studies. A feature of 
particular interest is the potential to make assembly inducible. In cells, 
retroviral assembly proceeds automatically when a sufficient level of Gag 
expression is reached. The lack of control post-expression imposes a time lag 
between the time that expression is induced and the time that assembly can 
be detected. For kinetic studies, it would be useful instead to be able to induce 
assembly of a pre-formed pool of Gag protein. One potential candidate for an 
inducible system of retroviral assembly is the Argent Regulated 
Homodimerization System developed by Ariad Pharmaceuticals. This system 
is based on the interaction of human FK506 binding protein (FKBP) and its 
ligand, the small molecule FK506, a natural product that acts as an 
immunosuppressive drug. Homodimerization of FKBP is induced with 
homobifunctional ligands in which two molecules of FK506 are tethered. 
These ligands penetrate the plasma membrane and are thus readily 
introduced into cells. Ariad has developed modified versions of FKBP (the 
mutant used in these studies is designated Fv1) and FK506 (AP20187 was 
used in these studies) which are specific to each other and do not interact with 
cellular FKBP domains (23). Therefore, fusion of a protein of interest to a 
modified FKBP domain, followed by introduction of the ligand, is expected to 
dimerize the protein of interest rapidly and specifically (Figure 4.3). 
Replacement of the NC domain of Gag with FKBP might allow for rapid, 
specific induction of retroviral assembly in cells or in vitro, which in turn could 
facilitate studies of retroviral assembly kinetics. 
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Figure 4.3: Principle of FKBP-FK506 inducible homodimerization system. 
The FKBP domain is fused to an effector domain. The homobifunctional 
FK506 ligand binds to two FKBP domains, forcing the effector domains to 
dimerize and potentiating an effect. Figure adapted from documentation for 
ARGENT™ Regulated Homodimerization Kit, Version 2.0, from ARIAD 
Pharmaceuticals, Inc.  
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RESULTS 
 
Gag-leucine zipper fusion does not bud consistently from avian cells 
 The Gag-leucine zipper fusion in which the leucine zipper domain 
replaces NC at the PR cleavage site assembles correctly in the baculovirus 
expression system but not in vitro. To clarify whether this construct is truly 
assembly competent, I moved the MA-CA-LZ, MA-CA-fLZ, and MA-CA 
constructs from the baculovirus study (56) into a CMV-driven vector (Figure 
4.4) and expressed these constructs in DF1 (embryonic chick fibroblast) cells 
by transient transfection. I used the previously described Gag-D37S construct 
(69), which was originally made in the same CMV-driven vector plasmid, as a 
positive control for budding. Budding was assayed by 35S-methionine labeling, 
SDS-PAGE, and autoradiography. 
 Initial results of these experiments were promising. Both the MA-CA-LZ 
and MA-CA-fLZ constructs were released from cells at readily-detectable 
levels (Figure 4.5). Consistent with previous results (56), the MA-CA 
construct, which lacks either NC or a dimerization domain, was not released, 
indicating that NC plays a role in assembly that can be replaced by the leucine 
zipper domain. Unfortunately, these results could not be reproduced 
consistently, and many transfections resulted in little to no release of the 
leucine zipper constructs (Figure 4.6, compare MA-CA-LZ “medium” lanes 
after 8 hours, top and bottom). Budding efficiency appeared to be related to 
the level of protein expression (Figure 4.6, compare MA-CA-LZ “lysate” lanes 
after 1 hour, top and bottom), but experiments to confirm this observation (for 
example, varying the amount of plasmid transfected into cells and comparing 
amount of DNA transfected to budding efficiency) were not performed. While  
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Figure 4.4: CMV-driven Gag constructs used for Gag dimerization studies 
in DF1 cells. D37S is an active site mutation that inactivates RSV PR. 
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Figure 4.5: Gag-leucine zipper fusion proteins bud from DF1 cells. Cells 
were transfected with indicated constructs, pulse-labeled with 35S 
methionine 24 hours post-transfection, and analyzed after a one hour 
chase. Top: Gag proteins immunoprecipitated from cell lysates using a 
mixture of α-CA and α-MA-p10 antibodies. Bottom: Gag particles pelleted 
from cell culture medium. Note that MA-CA does not bud. 
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Figure 4.6: Budding of Gag-leucine zipper fusion proteins was 
inconsistent. Two pulse-chase time courses are shown for comparison. 
Cells were pulse-labeled 24 hours post-transfection and analyzed after the 
chase time indicated. Top: Successful budding of MA-CA-LZ. Note strong 
appearance of lower Gag band in medium (right). Bottom: Poor budding 
of MA-CA-LZ. Note relative absence of lower Gag band in medium (right). 
 
 110
the budding rate for MA-CA-LZ was, at its best, comparable to that for Gag-
D37S (Figure 4.7), I was unable to obtain statistically useful data due to the 
inconsistency of budding. In light of the inconsistency, I judged thin section 
TEM to examine the particle morphology to be too time-consuming and did not 
attempt to perform it. My tentative conclusion based on these findings is that 
the substitution of the leucine zipper for the NC domain at the SP-NC cleavage 
site introduces a subtle assembly and/or budding defect that permits budding 
only under certain optimal conditions. 
 
Gag-leucine zipper fusions at the NC+4 position do not assemble in vitro 
 The failure to assemble a Gag-leucine zipper construct in vitro had 
been ascribed to the previously-unsuspected existence of a functional element 
including the first four amino acids of NC. To address this hypothesis, I 
generated a construct from ΔMBDΔPR in which the CREB bzip domain 
replaced NC at the NC+4 position. A five amino acid flexible linker (GSGSG) 
was included in order to minimize interference between the two domains 
(Figure 4.8). This construct was readily expressed in and purified from E. coli. 
Unfortunately, the construct failed to produce particles under standard in vitro 
assembly conditions (Figure 4.9). Furthermore, rate-zonal sedimentation 
analysis of ΔMBD-bzip did not show a significant fraction shift relative to 
monomeric ΔMBDΔPR, suggesting that the protein did not dimerize (Figure 
4.10) A second ΔMBD-bzip gradient was more ambiguous (data not shown), 
admitting the possibility that some degree of dimerization may have occurred 
in that experiment, but overall the evidence for dimerization of ΔMBD-bzip was 
not convincing. 
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Figure 4.7: Budding rate of MA-CA-LZ is comparable to that of Gag-
D37S. Budding is expressed as percentage of total Gag found in the 
medium at each time point. 
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 Figure 4.8: Constructs used for in vitro dimerization/assembly assays. 
Mutated amino acid residues are underlined. 
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Figure 4.9: Negative stained TEM images of wild-type and leucine zipper 
fusion proteins assembled in vitro. Scale bars represent 100 nm. Arrows 
denote VLP-like structures seen for ΔMBD-Kzip.
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Figure 4.10: Rate-zonal sedimentation analysis of leucine zipper fusion 
dimerization. Samples were loaded onto 10-30% sucrose gradients and 
centrifuged for 24 hours. Arrow indicates direction of sedimentation. 
ΔMBD (no DNA) is a monomeric control and ΔMBD + GT16 is a dimeric 
control. None of the zipper proteins appears to dimerize. 
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 It is possible that the protein fails to dimerize or assemble because 
dimerization-competent protein is lost during the purification process. This 
possibility was addressed by creating two pairs of heterodimeric leucine 
zippers. The first pair, designated Ezip/Kzip (Figure 4.8), had previously been 
used to assemble HIV-1 Gag in cells (137). All eight of the amino acids in the 
“e” and “g” positions flanking the hydrophobic interface were changed to either 
glutamic acid or lysine. These changes effectively prevent the formation of 
homodimers due to electrostatic repulsion but favor the formation of 
heterodimers (Figure 4.11). Neither protein is expected to dimerize or 
assemble when expressed alone, but dimerization and possibly assembly 
should occur when the two purified proteins are mixed. 
In practice, the Ezip fusion construct could not be expressed in E. coli, 
and the arrest in E. coli growth that occurred upon induction suggested that 
the protein was toxic (data not shown). The Kzip construct was efficiently 
expressed and purified using the standard protocol for ΔMBDΔPR. As Kzip 
carries a net positive charge, I hypothesized that it might function as a 
replacement for NC by electrostatic binding to nucleic acid. A single assembly 
trial was made by mixing the Kzip protein with 10% ssDNA under standard in 
vitro assembly conditions and examining by negative staining and TEM 
(Figure 4.9). While some of the protein debris was suggestive of assembly 
(Figure 4.9, arrows), no definite VLPs were observed. Nucleic acid-binding 
was not assayed and no attempt was made to determine whether the ratio of 
protein to nucleic acid was appropriate for this construct; therefore, it remains 
possible that ΔMBD-Kzip could assemble on nucleic acid if assembly 
conditions were optimized. 
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 Figure 4.11: Helical wheel representations of heterodimeric leucine zipper 
constructs. Mutated amino acid residues are underlined. Figure adapted 
from reference (76). 
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A final attempt at leucine zipper-mediated heterodimerization was made 
using the previously published heterodimeric zippers Zip3 and Zip12 (76). The 
investigators forced the proteins to heterodimerize by introducing electrostatic 
clashes at two e or g positions in each homodimer (Figure 4.11). In the 
original study, the a3 asparagine of Zip12 was mutated to histidine to prevent 
Zip12 from forming any homodimers. As including the histidine at a3 in both 
zippers prevented heterodimerization as well, the a3 asparagine of Zip3 was 
left in place. Since I did not prefer either possible homodimer, I restored the a3 
asparagine of Zip12 and changed only the charged residues in the e and g 
positions. Both ΔMBD-Zip3 and ΔMBD-Zip12 (Figure 4.8) were successfully 
expressed in and purified from E. coli, but they did not form VLPs either alone 
or when mixed (Figure 4.9). Rate-zonal sedimentation analysis showed that 
both proteins were monomeric in solution, but there was no evidence that the 
two proteins were able to form heterodimers when mixed (Figure 4.10). 
In conclusion, as of this writing I have not been able to demonstrate 
assembly of RSV Gag by leucine zipper-mediated dimerization. 
 
Gag-FKBP fusion proteins fail to respond to dimerization reagent 
 In order to investigate the possibility of an inducible Gag dimerization 
assembly system in cells, I generated a CMV-driven construct in which the 
modified FKBP domain Fv1 (which has mutations conferring altered ligand-
binding specificity (23)) replaced the NC domain of Gag at the SP-NC 
cleavage site. (This work was begun before the characterization of the CA-SP-
NC element.) The PR domain of Gag was not included. The resulting 
constructs were transfected into DF1 cells. After 24 hours, cells were treated 
with AP20187 (a homobifunctional FK506 analog that is bound by Fv1 but not 
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by cellular FKBP domains) at a range of concentrations. Cells and medium 
were harvested 24 hours after AP20187 treatment and analyzed by 
immunoblotting. Surprisingly, while the Gag-FKBP fusion did appear to bud 
from cells, the amount of Gag seen in the medium was approximately the 
same at every concentration of AP20187 used, including mock-treated cells 
that were not exposed to AP20187 at all (Figure 4.12). As budding was 
independent of AP20187, the FKBP fusion did not appear to function as 
predicted, I discontinued this line of investigation and did not perform thin 
section TEM to verify particle morphology. 
 I made a second attempt to assemble RSV Gag using inducible FKBP 
dimerization, this time in the in vitro assembly system. I generated a construct, 
ΔMBD-FKBP (Figure 4.8), in which the NC domain of the ΔMBDΔPR protein 
was replaced with FKBP at the NC+4 position (Figure 4.1). A five amino acid 
GSGSG linker was included at the Gag-FKBP junction. The FKBP domain 
included a C-terminal 6His tag separated from the FKBP sequence by a 3C 
protease cleavage site to allow for later removal of the 6His tag if desired. The 
fusion protein was expressed in E. coli and purified by Ni-NTA agarose 
chromatography.  
The ΔMBD-FKBP fusion protein was adjusted to standard in vitro 
assembly conditions and a stoichiometric concentration of 50% (10 μM) of 
AP20187 was added. The reaction was incubated under standard in vitro 
assembly conditions and assayed by negative staining and TEM. No virus-like 
particles were observed (data not shown). 
I then assayed whether the chimeric ΔMBD-FKBP protein was able to 
dimerize by diluting the protein to the in vitro assembly concentration (20 μM)  
 119
  
 
 
 
 
Figure 4.12: MA-CA-FKBP release from DF1 cells is independent of 
dimerizing ligand AP20187. Cells were treated with AP20187 24 hours 
post-transfection. Medium from cells was collected 24 hours post-
treatment and particles were collected as described in the Materials and 
Methods. Pellets were analyzed by SDS-PAGE and immunoblotting using 
α-CA antibody. Gag-D37S was used as a positive control for budding and 
MA-CA as a negative control.
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at pH 8.0, adding a stoichiometric amount (10 μM) of AP20187, and subjecting 
the mixture to rate-zonal sedimentation. No peak shift was observed in 
response to AP20187 (Figure 4.13), suggesting that the ΔMBD-FKBP fusion 
did not dimerize in response to AP20187. 
 
DISCUSSION 
 
 While the overall failure to produce RSV Gag assembly by artificial 
dimerization is disappointing, several aspects of these studies remain open for 
investigation. The success of leucine zipper-mediated assembly for HIV-1 and 
for RSV in the baculovirus system, and the partial success reported here for  
RSV in DF1 cells, all suggest that this approach might be viable under some 
as-yet unidentified set of conditions. 
 One possibility for the assembly failure of the Gag-leucine zipper fusion 
proteins presented here is that the CA-SP-NC element remains disrupted. The 
C-terminal extent of the element was defined by insertion of the GSGSG linker 
at various positions in NC (60). This approach leaves the remainder of the NC 
domain intact and is thus not entirely analogous to replacing the downstream 
portion with a completely different sequence. In fact, the constructs which 
couple the zipper domain directly to the end of SP and omit the last 4 amino 
acids of NC, such as the CMV-driven Gag-LZ used in this study and the MA-
CA-LZ construct used in the baculovirus study, have generally been more 
successful than those incorporating a linker between the Gag and zipper 
sequences. This trend, combined with the hypothesis that the CA-SP-NC 
element forms a long α-helix, suggests that the linker sequence itself may be 
detrimental to assembly, possibly by breaking a helix. The downstream portion  
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Figure 4.13: Rate-zonal sedimentation analysis of ΔMBD-FKBP 
dimerization in response to AP20187. Samples were loaded onto 10-30% 
sucrose gradients and centrifuged for 24 hours. The arrow represents the 
direction of sedimentation. The protein does not appear to dimerize in 
response to the drug. 
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of NC may be able to compensate for this putative helix-breaking in a way that 
the zipper domain cannot. It may also be noteworthy that the construct in 
which GSGSG was inserted at the NC+4 position, which appeared to produce 
normal particles in cells, assembled relatively poorly in vitro (59), leaving open 
the possibility of a subtle assembly defect that was not apparent in the cell-
based studies. Future studies in which the linker was eliminated and the 
position of the zipper fusion extended C-terminally might produce more 
favorable results, although the latter suggestion requires including basic 
residues of NC that could confound interpretation either by recruiting nucleic 
acid or, in the absence of nucleic acid, by interfering with Gag-Gag 
interactions due to electrostatic repulsion. 
 The failure of the purified Gag-zipper fusions even to dimerize in vitro 
suggests three possibilities. The first is that dimerization did in fact occur, as 
suggested by the single ambiguous ΔMBD-bzip gradient (data not shown), but 
that the method used to detect dimerization, rate-zonal sedimentation, was not 
sufficient to the task. It is true that small shifts of one or two gradient fractions 
may be masked by technical difficulties inherent in fractionating the gradients. 
It is also possible that the dilution that inevitably occurs as the protein moves 
down the sucrose gradient led to dissociation of any dimers that formed. 
Further experiments using more definitive techniques, size-exclusion 
chromatography for example, would be required to say definitively that the 
proteins do not dimerize in vitro. 
The second possibility is that mutation of the cysteine at the beginning 
of the zipper, intended to simplify future cross-linking studies, may have 
interfered with dimerization. I do not consider this probable, as cysteine to 
serine is a relatively conservative mutation and the cysteine is not part of the 
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dimer interface. This hypothesis could easily be tested by expressing CREB 
with the mutant zipper domain and assaying for dimerization. 
The most interesting of the possible explanations for the failure of the 
Gag-zipper fusions to dimerize is that the Gag moiety prevents dimerization. 
This would most likely occur by steric hindrance in which the Gag portion of 
the protein folds over and occludes the dimerization surface of the zipper. 
Studies of the HIV-1 Gag protein in solution suggest that Gag domains, rather 
than assuming an extended “beads on a string” arrangement, may interact 
with one another in solution, producing just such folded-over conformations 
(29). While the RSV in vitro assembly constructs lack the membrane-binding 
domain of MA, the C-terminal portion of MA that remains may interact with 
downstream sequences, or the SP segment may interact with upstream 
sequences. It might be profitable to repeat the dimerization studies on a CA-
SP-LZ fusion in order to examine the role of the upstream MA-p10 sequence. 
Eliminating the linker sequence or shifting the position of the zipper fusion 
might also decrease interference, but the effects of doing so are difficult to 
predict without more information on the conformation of RSV Gag under in 
vitro assembly conditions. 
 The failure of the FKBP-ligand dimerization system to perform as 
expected may be due to any of the considerations discussed above or to 
factors inherent to that system. Only one kit was purchased for these studies, 
and it is possible that the sample of AP20187 received was defective, or 
reconstituted improperly, or degraded over the period in which the studies 
were conducted. Alternatively, the Gag-FKBP fusions may in fact be dimeric 
without the drug, as suggested by the data presented above on the release of 
Gag-FKBP from DF1 cells. The FKBP domain appears to be capable of self-
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associating to some degree even in the absence of ligand (101), and this 
ligand-independent dimerization may be potentiated by the presence of 
upstream Gag sequence. In this scenario, the protein peak on the rate-zonal 
gradient failed to shift because the ligand-free protein was already dimeric, 
and the failure to assemble was due to other causes than failure to dimerize. It 
is also possible that kinetic factors were at fault. The FKBP-ligand dimerization 
system has been used primarily to induce cell signaling events, which may 
have very different requirements than does Gag assembly. Kinetics and 
thermodynamics are decoupled to some extent: if both the association and 
dissociation rates are high, individual dimers can be very short-lived even 
among molecules that are dimeric most of the time. It is possible that FKBP-
ligand dimerization, while high affinity, does not last long enough to initiate 
assembly. This hypothesis cannot, however, explain the failure of the protein 
peak on the rate-zonal gradient to shift in response to the addition of 
AP20187, as sedimentation should be a purely thermodynamic phenomenon. 
Overall, the FKBP-ligand system shows less promise for Gag assembly than 
does leucine zipper-mediated dimerization. Ariad notes that the system has 
not worked well for the transcriptional regulation, and it may be that Gag 
assembly is simply another inappropriate application.  
 Overall, a great deal of work remains to be done to explain the failure to 
assemble RSV Gag proteins by artificial dimerization. Such experiments are 
beyond the current scope of my thesis research, but possible future directions 
will be discussed in Chapter Five. 
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CHAPTER FIVE 
PERSPECTIVE 
 
 Thus far I have explored several different aspects of the assembly of 
the Rous Sarcoma Virus Gag protein into virus-like particles. In this chapter I 
will briefly summarize each of these projects, describe the significance of each 
to the field of retroviral assembly, and discuss remaining questions and 
possible directions for future research. 
 
Chapter 3 
• Summary: I performed a scanning alanine mutagenesis of the C-
terminal 25 amino acids of the p10 domain of Rous Sarcoma Virus Gag 
and found good correlation between those amino acids required for in 
vitro assembly and those whose side chains interacted with CA in a 
published RSV CA extended NTD dimer structure. This mutagenesis 
allowed me to identify a pair of amino acid residues that when mutated 
to cysteines would form a disulfide bond across the p10-CA interface. 
Subsequent cross-linking experiments established that the p10-CA 
interface depicted in the structure was present in assembled virus-like 
particles and that the interface formed a hexamer rather than the dimer 
found in the crystal structure. This information assisted our 
collaborators in constructing a coarse-grained molecular model of an 
immature RSV CA NTD hexamer incorporating the p10-CA interface. 
This model has some striking similarities to electron cryotomography 
data recently obtained for immature virus-like particles from HIV-1 and 
RSV. 
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• Impact: This line of research is unique in the retroviral assembly field. 
The interactions among Gag molecules in the immature particle have 
been poorly understood relative to those in the mature CA core. This 
study establishes a mechanism for the previously known importance of 
the last 25 amino acids of p10 for RSV particle morphology. It confirms 
the relevance of the published extended NTD structure to retroviral 
assembly and establishes this structure as the first known example of a 
protein-protein interaction involving heterologous Gag domains as well 
as the first and so far only high-resolution structure of a protein-protein 
interaction unique to the immature VLP. The interaction between p10 
and CA is also the best-characterized example of a contribution of a 
non-CA domain of Gag to protein-protein interactions during assembly 
(the role of the spacer domain between CA and NC and the significance 
of the internal “pillars” seen by cryotomography are not yet clear.) 
Finally, the role of p10 in stabilizing the immature CA NTD hexamer 
suggests a possible mechanism by which PR cleavage leads to 
morphological maturation of retroviral particles, the first such 
mechanism not confined to the β-hairpin formed at the N-terminus of 
CA upon cleavage. Overall, this work makes a highly significant 
contribution to our current knowledge of the structure and assembly of 
immature retroviral particles. 
 
Chapter 4 
• Summary: I attempted to replicate various results in which artificial 
dimerization of retroviral Gag proteins have been shown to initiate virus-
like particle assembly. I employed homodimeric and heterodimeric 
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leucine zipper fusions, as well as an inducible FKBP dimerization 
domain, in place of the RSV NC domain in both cell-based and in vitro 
assembly systems. I had only partial success in demonstrating budding 
of RSV Gag-leucine zipper fusions, previously reported in a baculovirus 
expression system, from avian cells and was unable to assemble VLPs 
in vitro using any system, although using a highly positively charged 
zipper in conjunction with nucleic acid produced VLP-like structures 
with low efficiency. All Gag-leucine zipper fusions tested, as well as the 
Gag-FKBP fusion, were unable to dimerize in vitro. 
• Impact: This work has not been published and will require a great deal 
of follow-up if it is to have any impact on the field.  
 
Future directions 
 My study of the role of the p10-CA interaction in RSV Gag assembly is 
largely complete as it stands; most of the remaining questions pertain to 
structural questions beyond my current training. For example, it would 
obviously be desirable to obtain isolated p10-NTD hexamers for high-
resolution structural study (full-length Gag is not likely to be amenable to 
crystallization or to NMR spectroscopy). Two approaches are possible: 
crystallization of an extended NTD under a variety of conditions in hope of 
obtaining spontaneous hexamerization, or cleavage of assembled (and 
possibly cross-linked) particles in hope of having an assembled p10-NTD or 
p10-CA hexamer left at the end. Neither of these approaches is particularly 
promising. The first relies on luck, and the second is most likely to be 
successful if upstream and downstream sequences are removed. This could 
be accomplished by incorporating the p10-CA cleavage site mutation 
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described in Chapter 3 and then digesting particles with RSV PR. However, 
the conditions required for in vitro PR digestion may themselves be 
detrimental to particle structure (see Appendix C). In addition, the CTD should 
be removed as well to increase the probability of crystallization, and insertion 
of exogenous retroviral protease sites is problematic as PR recognition 
sequences are highly variable. These difficulties could be overcome by 
inserting cleavage sites for a non-retroviral protease, such as TEV protease, 
into p10 and CA and digesting with that enzyme. Unfortunately, the linker 
region of CA is exquisitely sensitive to mutation, so insertion of any cleavage 
site between the NTD and the CTD is not likely to be successful. Finally, it is 
possible that NTD-CTD interactions or interhexamer NTD-NTD interactions 
may be required to stabilize the p10-NTD hexamer; interhexamer interactions 
seen for the helix 4-5 loop of the MLV NTD have been hypothesized to play a 
role in the immature lattice (87). If so, an isolated, authentic p10-NTD hexamer 
may be an impossible goal. 
 In another attempt to obtain detailed structural information on the 
immature hexamer, I sent samples of several proteins for analysis by two-
dimensional crystallography, a technique that has yielded valuable data on the 
mature HIV-1 lattice structure (44). The structures produced by RSV proteins 
displayed a persistent curvature, forming either spheres or tubes but no 
monolayers or crystals under any condition tested. Combined with the 
“conical” shape of the Gag hexamer (widest at the NTD and narrower beneath, 
with protein-protein interactions at multiple levels) shown by cryotomography, 
this suggests the novel possibility that some of the curvature displayed by 
immature cores is an inherent property of the hexameric lattice rather than a 
result of pentameric defects. The mathematical difficulties of this idea are 
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mitigated by the additional finding that the immature lattice is incomplete, with 
substantial areas of disorganization interspersed with areas of ordered 
hexamers (130). Unfortunately, for practical purposes, this hypothesis only 
increases the difficulty of obtaining structural information on the immature 
hexamer. 
 A third possibility for structural verification of the p10-CA hexamer 
model would be to examine the p10-CA interface for evidence of protection for 
hydrogen-deuterium exchange using mass spectroscopy. This technique has 
been used successfully to identify a novel NTD-CTD interface in HIV-1 (68) 
which was later confirmed by 2D crystallography (44) and by assembly 
interference by a small molecule that binds the CTD side of the interface 
(Vanda Bartonova, personal communication). Protection of both the p10 and 
CA sides of the interface in particles relative to unassembled protein would be 
further evidence of the existence of the interface in particles. It would not 
directly address whether the interface is truly hexameric, although mass 
spectroscopy could also be used to verify the size of the disulfide-linked 
complexes isolated from oxidized CC VLPs. Collaborations on these topics 
have been discussed and may be forthcoming following the completion of this 
thesis. 
 Other remaining questions pertain mostly to peripheral issues. For 
example, it is not known whether assembly and nuclear export of RSV Gag, 
which have overlapping amino acid requirements, are actually functionally 
related. Since the key amino acids of the L-W-V-L NES recognized by the 
cellular nuclear export factor CRM-1 are also involved in the p10-CA interface, 
it seems logical that only unassembled Gag can be exported from the nucleus, 
as assembly would occlude the NES. If this is the case, one might ask whether 
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the virus or cell has a mechanism (beyond lack of plasma membrane) to 
prevent nonproductive and potentially toxic nuclear assembly when both Gag 
and nucleic acid are present in abundance. Alternatively, as nuclear transit of 
Gag appears to be required for packaging of dimeric RNA, it may be that 
multiple interacting Gag molecules are required to “collect” the dimeric RNA 
and export it from the nucleus. To test this hypothesis, one might ask whether 
an assembly-defective Gag species with an intact NES (such as the p10 T43A 
mutant) could rescue nuclear export of an NES mutant; unfortunately, since all 
NES mutants examined to date are also defective for assembly, such an 
experiment is unlikely to be definitive. The relationship between the assembly 
and nuclear export functions of the p10 domain of RSV Gag will be difficult to 
study as the two appear to be inseparable. 
 Another question is whether cross-linking the p10 domain of Gag to CA 
would fix the VLP in its immature morphology even after PR cleavage. While 
conceptually simple, this experiment would be technically difficult for a number 
of reasons. First, neither the relative timing of oxidation and PR cleavage nor 
even the timing of either relative to budding is known. The cytoplasm is 
generally a reducing environment, with disulfide bond formation taking place in 
the lumen of the endoplasmic reticulum (3). I assume, therefore, that the CC(-
11C) Gag particles produced from cells in Chapter 3 became oxidized only 
after budding and release. PR cleavage appears to take place in the same 
timeframe. Therefore, simply expressing Gag with both the E51C-T20C double 
mutation and an active protease and examining the particles produced by thin-
section TEM would not be useful, as there would be no way of knowing 
whether oxidation had taken place prior to PR cleavage. Immature particles 
could be digested in trans by purified PR, as was done in Chapter 3, but 
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recovering the digested particles for TEM analysis is likely to be challenging, 
as permeabilizing the membrane sufficiently to allow PR access to the 
immature Gag core would also allow Gag cleavage products to diffuse away, 
potentially inhibiting mature core assembly. In addition, digestion in trans of 
sufficient amounts of virus for pelleting and thin-sectioning, as opposed to 
biochemistry, might be difficult. Overall, while I am confident that cross-linked 
particles would resist morphological maturation, I fear that the technical 
challenges to proving so may be insurmountable. 
 The artificial dimerization project, being less complete, leaves much 
more scope for future exploration. The most pressing question is why the 
homodimeric Gag-leucine zipper chimera (ΔMBD-bzip) fails to dimerize in 
vitro. While it is possible that the cysteine to serine mutation described in 
Chapter 4 abrogates dimerization (and this hypothesis would be simple to 
test), it seems more likely that the Gag moiety of the protein inhibits 
dimerization, most likely by assuming a conformation that occludes the 
dimerization surface of the zipper. A possible key to this problem is the 
observation that the ΔMBD-Kzip mutant protein, which is extremely unlikely to 
homodimerize due to electrostatic repulsion, produces structures reminiscent 
of VLPs when mixed with nucleic acid under assembly conditions. This finding 
hints at an assembly role beyond Gag oligomerization for NC-nucleic acid 
binding.  
 Since ΔMBD-Kzip lacks all but the first four amino acids of NC, this role 
cannot require any nucleic acid-induced conformational change in the NC 
domain itself but must involve some other part of Gag. The most likely 
candidate by physical proximity is the upstream CA-SP-NC element (Figure 
4.1). An interaction between this element and nucleic acid is not 
 132
unprecedented; an unpublished NMR structure of the CTD-NC portion of RSV 
Gag suggests an interaction between SP and the CTD that disappears upon 
nucleic acid binding (Carol Post, personal communication). The SP domain fits 
into a hydrophobic groove between helices 1 and 4 of the CTD. The 
mechanism by which nucleic acid binding displaces SP from the groove is not 
known.  
 As the groove itself is conserved among retroviral CA domains (64), the 
auto-inhibition and release mechanisms may be conserved as well. This begs 
the question of how artificially dimerized HIV-1 Gag constructs are able to 
assemble in vitro in the absence of nucleic acid. One possibility is that part of 
the NC domain is required for auto-inhibition. It may be that some NC 
sequence that is required for auto-inhibition but not for assembly is missing 
from the artificially dimerized HIV-1 Gag constructs described to date, none of 
which have included NC sequence. This might also explain why the cell based 
RSV constructs, which lacked any NC sequence, performed better than the in 
vitro constructs containing the first four amino acids of NC. As discussed in 
Chapter 4, the presence of the GSGSG linker between the Gag and zipper 
sequences (Figure 4.8) may also have disrupted assembly, as evidenced by 
the switch from spherical to cylindrical particles in the baculovirus expression 
system (56) (Figure 4.2). However, I consider differences between cellular 
and in vitro assembly systems – such as cellular chaperone activity and the 
presence of membranes – more likely than the sequence differences to be 
responsible for the discrepant performances of the leucine zipper fusions in 
these systems. 
 While they may not account for the differences between in vitro and 
cell-based assembly, the potential roles of the CA-SP-NC element and the 
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GSGSG linker in the failure of the ΔMBD-bzip construct to dimerize in vitro 
require further investigation. I would begin by building a series of constructs in 
which the mutated zipper domain of ΔMBD-bzip was replaced by a wild-type 
leucine zipper domain, with and without the GSGSG linker. (Comparison of the 
CREB and GCN4 zippers might be productive as well; all of the RSV Gag-
zipper fusions described in this thesis, as well as those previously published 
(56), have used the former, while some of the HIV-1 fusions have used the 
latter (1)). In vitro dimerization of a ΔMBD-bzip fusion lacking the cysteine to 
serine mutation would indicate that the mutation was at fault, while 
dimerization of a chimera lacking the GSGSG sequence would implicate the 
linker. If these constructs failed to dimerize, I would truncate the Gag 
sequence to remove first the remaining N-terminal four amino acids of NC and 
then the entire SP domain (Figure 4.1), again with and without the GSGSG 
linker. This would indicate whether an auto-inhibitory conformation of the CA-
SP-NC element was responsible for the failure to dimerize. As a control, I 
would also build a full-length ΔMBDΔPR construct with the wild-type zipper 
domain fused at the end of NC and test for dimerization in the presence and 
absence of GT8, an eight-base ssDNA oligonucleotide that can bind only one 
NC domain and does not induce ΔMBDΔPR dimerization (79). Dimerization of 
this construct only in the presence of GT8 would suggest that the auto-
inhibition is relieved by nucleic acid binding as predicted by NMR. These 
experiments would lay necessary groundwork for understanding artificial Gag 
dimerization. 
 The observation that assembly was normal in cells but poor in vitro 
when the NC sequence was interrupted by GSGSG at the NC+4 position 
suggests that the requirements for the CA-SP-NC element may be more 
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stringent for in vitro assembly. This too requires further investigation, as 
inclusion of a functional CA-SP-NC element will be required to build a Gag 
construct that assembles by artificial dimerization. Since the in vitro assembly 
system appears to be more sensitive to disruption of this element than cell-
based assembly, I would forego the original strategy of GSGSG insertion and 
begin with a scanning single or double alanine mutagenesis of the entire CA-
SP-NC element (as currently defined in Figure 4.1) in the ΔMBDΔPR 
construct and screen the resulting proteins for assembly in vitro. Depending on 
the results, I would extend this screen further into the NC domain to include all 
amino acids up to the first zinc finger. This region encompasses 20 amino 
acids with a net charge of +2 and is not sufficient for in vitro assembly without 
additional basic residues (133), so while the sequence does contain four basic 
amino acids, I do not anticipate that including any or all of it in a leucine zipper 
chimera would induce assembly by nucleic acid-mediated oligomerization. The 
conservative alanine substitution mutagenesis proposed could be followed by 
insertional mutagenesis as performed in the baculovirus system (60) once the 
less sensitive sites are identified. These screens should better characterize 
the CA-SP-NC element for in vitro assembly which, combined with additional 
information on the requirements for Gag dimerization, should suggest a more 
focused approach to designing an RSV in vitro assembly construct driven by 
artificial dimerization. 
 Mutagenesis of the CA-SP-NC element in the context of the in vitro 
assembly system would have a second purpose: as a preliminary to further 
exploration of the relationship of this element to the pillar-like structures 
observed by cryotomography. Small insertions into less-sensitive parts of the 
element, or mutation of dispensable amino acids to cysteine followed by 
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labeling with maleimide-conjugated Undecagold beads (Nanoprobes, Inc.), 
would be detectable by cryotomography and could demonstrate which parts of 
the sequence correspond to which parts of the pillars. The collaborator who 
performed the initial RSV cryotomography study is highly interested in 
pursuing this line of research if the necessary reagents (purified VLPs 
assembled from mutant proteins) can be provided. Clarifying the identity and 
function of these unexpected structures would be a most valuable contribution 
to the retroviral assembly field. 
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APPENDIX A 
 
Homobifunctional maleimide cross-linking of exogenous cysteine in 
helix 6 of the CA NTD 
 Helix 6 of the N-terminal domain of RSV CA forms part of the dimer 
interface in the extended NTD structure. Unlike the p10-CA portion of the 
dimer interface, the helix 6 portion of the dimer interface is symmetrical (helix 
6 interacts with helix 6). Prior to the alanine mutagenesis of p10, I attempted to 
demonstrate the existence of the extended NTD interface in virus-like particles 
by introducing an exogenous cysteine residue into helix 6 and cross-linking 
using a homobifunctional maleimide reagent, BMH.  
 This project was undertaken in collaboration with Marc Johnson, then a 
postdoctoral associate in this laboratory, who selected three candidate amino 
acids in helix 6 for cysteine mutagenesis and generated the mutations in the 
context of the pET3xc.p10CANC(-6C) vector. The three amino acids mutated 
(numbered by position in CA) were D111, G112, and L124.  
 I expressed and purified these constructs and screened them for 
assembly in vitro. Of the three constructs, only p10-L124C-NC(-6C) was able 
to assemble (Figure A.1). No BMH-mediated cross-linking of the negative 
control protein, p10CANC(-6C), was observed unless the protein was treated 
with 6.5 M urea (Figure A.1), suggesting that the endogenous cysteine C192, 
the side chain of which is buried in the RSV CTD structure (64), was not 
accessible to BMH and would not interfere with the cross-linking assay. 
 Unfortunately, cross-linking of the p10-L124C-NC(-6C) protein was not 
specific to VLP assembly. The degree of dimer formation seen was the same 
whether or not nucleic acid (required for assembly) was added to the  
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 Figure A.1: Cross-linking at helix 6 of CA-NTD. A. In vitro assembly of 
p10-L124C-NC(-6C). B. Endogenous C192 does not cross-link in the 
absence of urea. C. Cross-linking of exogenous C124 is not specific to 
assembly. T = total reaction, S = supernatant, P = pellet. 
 
 138
assembly reaction (Figure A.1). I also tested for specificity by increasing the 
concentration of BMH used, on the assumption that kinetics would favor cross-
linking of closely apposed cysteines (as in a VLP) even in the presence of 
excess BMH, whereas non-specific cross-linking of monomeric protein would 
decrease in the presence of excess BMH. No decrease in dimer formation with 
increasing BMH was observed for ΔMBDΔPR, suggesting that cross-linking 
was taking place between the NC or MA-p2 domains within assembled VLPs; 
however, decreased dimerization with increasing BMH was observed for p10-
L124C-NC(-6C) (Figure A.2), suggesting that the dimerization observed 
occurred nonspecifically between molecules randomly colliding in solution. I 
concluded that the helix 6 interface in the extended NTD structure could not be 
demonstrated in VLPs by cysteine cross-linking. 
 The results presented in Chapter Three of this thesis, which were 
obtained after the experiments described above, suggest several additional 
considerations. In light of the differences seen in Chapter Three when 
comparing purified particles (Figure 3.10) to total assembly reactions (Figure 
3.6) and unassembled protein (Figure 3.9), it is possible that I would have 
obtained different results had I purified particles prior to BMH cross-linking. I 
consider this possibility unlikely, as it appears that the majority of the cross-
linking observed was in fact non-specific. Furthermore, the helix 6-helix 6 
interaction cannot exist as part of the putative p10-NTD hexamer depicted in 
Figure 3.17, since helix 6 is not part of the NTD-NTD interface. It remains 
possible that helix 6 of the CA NTD forms inter-hexamer contacts. BMH cross-
linking of purified particles might demonstrate just such contacts. However, the 
presence of inter-hexamer CA-CA contacts would be difficult to prove as p10-
CA disulfide cross-linking and CA-CA BMH cross-linking could not be  
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Figure A.2: p10-L124C-NC(-6C) dimer crosslinking decreases with increasing 
concentration of BMH. Top: ΔMBDΔPR control. Bottom: p10-L124C-NC(-6C). 
Note decreasing intensity of dimer band from left to right. 
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performed simultaneously; maleimide-based reagents react only with reduced 
sulfhydryl groups, and hence the BMH experiments were carried out in the 
presence of Tris(2-carboxyethyl) phosphine (TCEP), a non-sulfhydryl reducing 
agent. Overall, I would hypothesize that the helix 6 portion of the extended 
NTD dimer interface is a crystallization artifact. 
 141
APPENDIX B 
 
Mutagenesis of solvent-exposed side chains in helix 2 of the CA CTD 
 May Ma, then a graduate student in this laboratory, had previously 
hypothesized based on indirect evidence that dimerization of the C-terminal 
domain of RSV CA is pH-sensitive and occurs much more efficiently at pH 6.5 
than at pH 8.0. I hypothesized that this pH-sensitivity might map to the D191 
residue of CA, which projects from helix 2 of the CTD analogously to the two 
amino acids that form the traditional side-by-side HIV CTD dimer interface. 
The pKa of the aspartate side chain is ordinarily only 3.9 (25), but side chain 
pKa values are dependent on the local peptide environment (i.e., a basic 
environment will lower the pKa of an acidic side chain, while a hydrophobic or 
acidic environment will raise it) so it is possible that the actual pKa of D191 is 
much higher. Furthermore, the other side chain that projects from helix 2 is 
that of R194, suggesting the possibility that these two residues interact across 
the CTD dimer interface in an electrostatic manner. 
 In order to test these hypotheses, I made a series of mutations of 
D191 and R194 and tested the resulting constructs for assembly in vitro. Of 
several single and double mutants tested, only ΔMBD-R194K was able to 
assemble in vitro (Table B.1, Figure B.1). Subsequent structural studies 
performed by another group suggest that D191 participates in hydrogen 
bonding (though not with R194) across a crystallographic CTD dimer interface 
(Richard Kingston, personal communication), suggesting an alternate 
hypothesis for the pH-sensitivity of the CTD and the importance of D191 to 
assembly. 
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Table B.1: CA-CTD helix 2 mutant constructs and in vitro assembly 
results. Amino acid numbering is based on position in CA. 
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Figure B.1: Negative-stained TEM of ΔMBD-R194K particles. 
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APPENDIX C 
 
Disassembly of virus-like particles assembled in vitro 
 Following the p10-CA cross-linking studies, I sought to determine the 
minimal conditions under which in vitro-assembled VLPs would disassemble. 
Initial results were promising: when 500 mM NaCl or 1 M urea was added to 
fresh in vitro assembly reactions and incubated for one hour, the particles that 
formed no longer pelleted, suggesting that the particles had disassembled 
(Figure C.1). In addition, the E51C-T20C mutant protein discussed in Chapter 
3 (Figure 3.4) pelleted in the presence of 500 mM NaCl when oxidized but not 
when oxidized and then reduced (Figure C.1), suggesting that the p10-NTD 
interface was specifically sensitive to salt. 
 Unfortunately, these results did not hold up to further study. Purified 
particles that were pelleted and resuspended in buffer containing 500 mM salt 
pelleted again during rate-zonal centrifugation, although particles resuspended 
with 1 M urea did not (Figure C.2). The particles resuspended with urea 
sedimented approximately twice as far as the unassembled protein, consistent 
with a ΔMBDΔPR hexamer. I interpret this peak as a protein-DNA complex, as 
the NC-nucleic acid interaction is electrostatic and should not be disrupted by 
1 M urea. As the oligonucleotide used, GT50, is expected to bind 
approximately six molecules of ΔMBDΔPR (the NC binding site size is 8 nt), so 
it is not possible to say whether any protein-protein interactions contributed to 
the complex; further experiments with different sized oligonucleotides would 
be informative. 
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Figure C.1: Pelleting of assembly reactions in the presence of urea and salt. 
Top: ΔMBDΔPR assemblies pelleted in the presence of urea. S = supernatant 
and P = pellet. Bottom: CC(-11C) proteins pelleted in the presence of high 
salt with and without oxidation and added urea. P = pellet; supernatants were 
not loaded. 
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Figure C.2: Rate zonal sedimentation analysis of purified ΔMBDΔPR VLPs 
resuspended with high salt or urea. The centrifugation was performed on 10-
30% sucrose gradients made in 50 mM Tris pH 8.0 with salt and urea as 
noted. Unassembled protein was run under each condtion as a monomeric 
sedimentation standard. Fraction 17 is the pellet at the bottom of the gradient. 
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 Pelleted particles resuspended with 500 mM NaCl also “reassembled” 
more efficiently than those resuspended with 1 M urea (Figure C.3) upon 
dialysis back to assembly conditions (50 mM MES pH 6.5, 100 mM NaCl), 
suggesting that the pelleted particles may not have disassembled after all. 
 I can think of two hypotheses to explain these discrepancies. First, the 
initial studies used E51C-T20C(-11C) mutant protein to allow for NTD cross-
linking, while the follow-up studies used ΔMBDΔPR. It is possible that there is 
a difference in the disassembly properties of the two proteins. Second, the 
purification of the particles in the follow-up studies required an additional four 
hours for equilibrium sedimentation, and the particles may become resistant to 
disassembly after this prolonged incubation. Further experiments would be 
required to test these hypotheses. 
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Figure C.3: TEM of virus-like particles “reassembled” by dialysis after 
purification and resuspension under the indicated conditions. Scale bars 
represent 100 nm. 
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